Aims. BoneMaster is a thin electrochemically applied hydroxyapatite (HA) coating for orthopaedic implants that is quickly resorbed during osseointegration. Early stabilization is a surrogacy marker of good survival of femoral stems. The hypothesis of this study was that a BoneMaster coating yields a fast early and lasting fixation of stems. Methods. A total of 53 patients were randomized to be treated using Bi-Metric cementless femoral stems with either only a porous titanium plasma-sprayed coating (P group) or a porous titanium plasma-sprayed coating with an additional BoneMaster coating (PBM group). The patients were examined with radiostereometry until five years after surgery. Results. At three months, the mean total translation (TT) was 0.95 mm (95% confidence interval (CI) 0.68 to 1.22) in the P group and 0.57 mm (95% CI 0.31 to 0.83) in the PBM group (p = 0.047). From two to five years, the TT increased by a mean of 0.14 mm (95% CI 0.03 to 0.25) more in the P group than in the PBM group (p = 0.021). In osteopenic patients (n = 20), the mean TT after three months was 1.61 mm (95% CI 1.03 to 2.20) in the P group and 0.73 mm (95% CI 0.25 to 1.21) in the PBM group (p = 0.023). After 60 months, the mean TT in osteopenic patients was 1.87 mm (95% CI 1.24 to 2.50) in the P group and 0.82 mm (95% CI 0.30 to 1.33) in the PBM group (p = 0.011). Conclusion. There was less early and midterm migration of cementless stems with BoneMaster coating compared with those with only a porous titanium plasma-sprayed coating. Although a BoneMaster coating seems to be important for stem fixation, especially in osteopenic patients, further research is warranted. Cite this article: Bone Joint J 2022;104-B(6):647–656

Objectives. We have observed clinical cases where bone is formed in the overlaying muscle covering surgically created bone defects treated with a hydroxyapatite/calcium sulphate biomaterial. Our objective was to investigate the osteoinductive potential of the biomaterial and to determine if growth factors secreted from local bone cells induce osteoblastic differentiation of muscle cells. Materials and Methods. We seeded mouse skeletal muscle cells C2C12 on the hydroxyapatite/calcium sulphate biomaterial and the phenotype of the cells was analysed. To mimic surgical conditions with leakage of extra cellular matrix (ECM) proteins and growth factors, we cultured rat bone cells ROS 17/2.8 in a bioreactor and harvested the secreted proteins. The secretome was added to rat muscle cells L6. The phenotype of the muscle cells after treatment with the media was assessed using immunostaining and light microscopy. Results. C2C12 cells differentiated into osteoblast-like cells expressing prominent bone markers after seeding on the biomaterial. The conditioned media of the ROS 17/2.8 contained bone morphogenetic protein-2 (BMP-2 8.4 ng/mg, standard deviation (. sd. ) 0.8) and BMP-7 (50.6 ng/mg, . sd. 2.2). In vitro, this secretome induced differentiation of skeletal muscle cells L6 towards an osteogenic lineage. Conclusion. Extra cellular matrix proteins and growth factors leaking from a bone cavity, along with a ceramic biomaterial, can synergistically enhance the process of ectopic ossification. The overlaying muscle acts as an osteoinductive niche, and provides the required cells for bone formation. Cite this article: D. B. Raina, A. Gupta, M. M. Petersen, W. Hettwer, M. McNally, M. Tägil, M-H. Zheng, A. Kumar, L. Lidgren. Muscle as an osteoinductive niche for local bone formation with the use of a biphasic calcium sulphate/hydroxyapatite biomaterial. Bone Joint Res 2016;5:500–511. DOI: 10.1302/2046-3758.510.BJR-2016-0133.R1

Aims. Biofilm formation is intrinsic to prosthetic joint infection (PJI). In the current study, we evaluated the effects of silver-containing hydroxyapatite (Ag-HA) coating and vancomycin (VCM) on methicillin-resistant Staphylococcus aureus (MRSA) biofilm formation. Methods. Pure titanium discs (Ti discs), Ti discs coated with HA (HA discs), and 3% Ag-HA discs developed using a thermal spraying were inoculated with MRSA suspensions containing a mean in vitro 4.3 (SD 0.8) x 10. 6. or 43.0 (SD 8.4) x 10. 5. colony-forming units (CFUs). Immediately after MRSA inoculation, sterile phosphate-buffered saline or VCM (20 µg/ml) was added, and the discs were incubated for 24 hours at 37°C. Viable cell counting, 3D confocal laser scanning microscopy with Airyscan, and scanning electron microscopy were then performed. HA discs and Ag HA discs were implanted subcutaneously in vivo in the dorsum of rats, and MRSA suspensions containing a mean in vivo 7.2 (SD 0.4) x 10. 6.   or 72.0 (SD 4.2) x 10. 5.   CFUs were inoculated on the discs. VCM was injected subcutaneously daily every 12 hours followed by viable cell counting. Results. Biofilms that formed on HA discs were thicker and larger than those on Ti discs, whereas those on Ag-HA discs were thinner and smaller than those on Ti discs. Viable bacterial counts in vivo revealed that Ag-HA combined with VCM was the most effective treatment. Conclusion. Ag-HA with VCM has a potential synergistic effect in reducing MRSA biofilm formation and can thus be useful for preventing and treating PJI. Cite this article:Bone Joint Res. 2020;9(5):211–218

The success of long-term transcutaneous implants depends on dermal attachment to prevent downgrowth of the epithelium and infection. Hydroxyapatite (HA) coatings and fibronectin (Fn) have independently been shown to regulate fibroblast activity and improve attachment. In an attempt to enhance this phenomenon we adsorbed Fn onto HA-coated substrates. Our study was designed to test the hypothesis that adsorption of Fn onto HA produces a surface that will increase the attachment of dermal fibroblasts better than HA alone or titanium alloy controls. . Iodinated Fn was used to investigate the durability of the protein coating and a bioassay using human dermal fibroblasts was performed to assess the effects of the coating on cell attachment. Cell attachment data were compared with those for HA alone and titanium alloy controls at one, four and 24 hours. Protein attachment peaked within one hour of incubation and the maximum binding efficiency was achieved with an initial droplet of 1000 ng. We showed that after 24 hours one-fifth of the initial Fn coating remained on the substrates, and this resulted in a significant, three-, four-, and sevenfold increase in dermal fibroblast attachment strength compared to uncoated controls at one, four and 24 hours, respectively

Objectives

An experimental rabbit model was used to test the null hypothesis, that there is no difference in new bone formation around uncoated titanium discs compared with coated titanium discs when implanted into the muscles of rabbits.

Bone defects require implantable graft substitutes, especially porous and biodegradable biomaterial for tissue regeneration. The aim of this study was to fabricate and assess a 3D-printed biodegradable hydroxyapatite/calcium carbonate scaffold for bone regeneration. Materials and methods:. A 3D-printed biodegradable biomaterial containing calcium phosphate and aragonite (calcium carbonate) was fabricated using a Bioplotter. The physicochemical properties of the material were characterised. The materials were assessed in vitro for cytotoxicity and ostegenic potential and in vivo in rat intercondylar Φ3mm bone defect model for 3 months and Φ5mm of mini pig femoral bone defects for 6 months. The results showed that the materials contained hydroxyapatite and calcium carbonate, with the compression strength of 2.49± 0.2 MPa, pore size of 300.00 ± 41mm, and porosity of 40.±3%. The hydroxyapatite/aragonite was not cytotoxic and it promoted osteogenic differentiation of human umbilical cord matrix mesenchymal stem cells in vitro. After implantation, the bone defects were healed in the treatment group whereas the defect of controlled group with gelatin sponge implantation remained non-union. hydroxyapatite/aragonite fully integrated with host bone tissue and bridged the defects in 2 months, and significant biodegradation was followed by host new bone formation. After implantation into Φ5mm femoral defects in mini pigs hydroxyapatite/aragonite were completed degraded in 6 months and fully replaced by host bone formation, which matched the healing and degradation of porcine allogenic bone graft. In conclusion, hydroxyapatite/aragonite is a suitable new scaffold for bone regeneration. The calcium carbonate in the materials may have played an important role in osteogenesis and material biodegradation

Introduction. To evaluate the effect of hydroxyapatite coating, two same shape cementless stems were compared in this randomized control trial study. Methods. Between May 2003 and February 2010, 88 patients had a primary cementless total hip arthroplasty with two different types of cementless stems. Forty-three patients had Proarc stems (P group) (Kyocera Medical, Osaka, Japan), and Forty-five patients had Proarc HA stems (HA group) (Kyocera Medical, Osaka, Japan) which was coated with thin (20 micrometer) hydroxyapatite on Proarc rough porous coating. Gender distribution, average age at surgery, average weight and average follow-up period were same in the two groups. The average follow-up period was 8.5 years (range, 5 to 13 years). The average age at the time of surgery was 63 years. Porous acetabular shells and highly crosslinked polyethylene liners made by Kyocera Medical corporation were implanted into all hips. Stems were implanted with a modified Hardinge surgical approach without trochanteric osteotomy. Harris Hip Score was used for clinical evaluation. Post-op radiographs of these patients were evaluated. Fisher's exact probability test was used for statistical analysis. P values of less than 0.05 were considered to be significant. Results. The mean preoperative score and postoperative score of P group were 39 points and 86 points, respectively. The mean preoperative score and postoperative score of HA group were 46 points and 87 points, respectively. All stems were evaluated as bone-ingrown fixation in both groups. The rate of varus inclination was not different between two groups. The rate of severe stress shielding was not different. Discussion. However hydroxyapatite coating is useful for early fixation, the adverse effect, such as delamination for long-term in vivo situation is questionable. There was no significant difference between P-group and HA group in the present study. Longer follow-up is required to evaluate hydroxyapatite coating

Targeted delivery of drugs is a major challenge in diseases such as infections and tumors. The aim of this study was to demonstrate that hydroxyapatite (HA) particles can act as a recruiting moiety for various bioactive molecules and as a proof-of-concept demonstrate that the affinity of drugs to hydroxyapatite can exert a biological effect. A bisphosphonate, zoledronic acid (ZA), was used as a model drug. Experiment 1 (ZA seeks HA): Calcium sulphate (CaS)/hydroxyapatite (HA) biomaterial pellets (diameter¸=5 mm, height=2 mm) were implanted in the abdominal muscle pouch of rats. After 2-weeks of implantation, a sub-cutaneous injection of 14C-ZA (0.1 mg/kg) was given. 24 h later, the animals were sacrificed and the uptake of ZA determined in the pellets using scintillation counting. Experiment 2 (Systemically administered ZA seeks HA and exerts a biological effect): A fenestrated implant was filled with the CaS/HA biomaterial and inserted in the proximal tibia of rats. 2-weeks post-op, a subcutaneous injection of ZA (0.1 mg/kg) was given. Animals were sacrificed at 6-weeks post-op. Empty implant was used as a control. Peri-implant bone formation was evaluated using different techniques such as micro-CT, mechanical testing and histology. Welch's t-test was used for mechanical testing and Mann-Whitney U test for micro-CT data analysis. Experiment 1: Uptake of radioactive ZA in the CaS/HA biomaterial was confirmed. Almost no ZA was present in the surrounding muscle. These results show high specific binding between systemically administered ZA and synthetic particulate HA. Experiment 2: Significantly higher peri-implant bone was measured using micro-CT in the group wherein the implant contained the CaS/HA biomaterial and ZA was administered systemically (This study presents a method for biomodulating HA in situ by different bioactive molecules. The approach of implanting a biomaterial capable of recruiting systemically given drugs and thereby activate the material is novel and may present a possibility to treat bone infections or tumors

Aims. This study reports the results of 38 total hip arthroplasties (THAs) in 33 patients aged less than 50 years, using the JRI Furlong hydroxyapatite ceramic (HAC)-coated femoral component. Methods. We describe the survival, radiological, and functional outcomes of 33 patients (38 THAs) at a mean follow-up of 27 years (25 to 32) between 1988 and 2018. Results. Of the surviving 30 patients (34 THAs), there were four periprosthetic fractures: one underwent femoral revision after 21 years, two had surgical fixation as the stem was deemed stable, and one was treated nonoperatively due to the patient’s comorbidities. The periprosthetic fracture patients showed radiological evidence of change in bone stock around the femoral stem, which may have contributed to the fractures; this was reflected in change of the canal flare index at the proximal femur. Two patients (two hips) were lost to follow-up. Using aseptic loosening as the endpoint, 16 patients (18 hips; 48%) needed acetabular revision. None of the femoral components were revised for aseptic loosening, demonstrating 100% survival. The estimate of the cumulative proportion surviving for revisions due to any cause was 0.97 (standard error 0.03). Conclusion. In young patients with high demands, the Furlong HAC-coated femoral component gives excellent long-term results. Cite this article: Bone Jt Open 2024;5(4):286–293

Hydroxyapatite (HAp) is a well-known synthetic biomaterial that has been extensively employed in orthopedic fields as bone grafts or coating of metallic implants. During recent years, ion doping or ionic substitution has been used to improve the performance of bioceramics. Owing to the benefits of a bioactive element such as boron (B) in bone health, and reported impaired bone growth or abnormal development of bone in case of boron deficiency, it was expected that doping of boron could make a positive effect on physicochemical and biological properties of HAp. In this study, boron-doped hydroxyapatite (BHAp) was synthesized successfully through utilizing microwaved assisted wet precipitation route. X-ray diffraction, scanning electron microscopy, and inductively coupled plasma mass spectrometry were used to characterize the phase purity, lattice parameters, degree of crystallinity, particle size and elemental composition of synthesized BHAp powders. Substitution of borate (BO. 3. 3-. ) ion with the phosphate (PO. 4. 3-. ) in HAp crystal caused lattice distortion due to radius difference between the dopant and the replaced element, which also led to smaller crystalline size and lower crystallinity degree in doped samples (∼ 91 % in 0.5 mol doped BHAp compared to 95 % of pure HAp). In vitro results revealed that although there was no significant difference in biodegradability of doped BHAp, after submerging samples in simulated body fluid for 14 days, intense growth of apatite particles (Ca/P ratio of 1.74) was observed on the surface of BHAp pellets, especially in samples with 0.25 and 0.5 mole B. Observed higher bioactivity was expected due to lower crystallinity degree of BHAp samples. Due to the results of this study, incorporation of B into the structure of HAp could be considered as a positive step to improve the bioactivity and biological performance of these biomaterials in orthopedic applications

The long-term results of grafting with hydroxyapatite granules for acetabular deficiency in revision total hip replacement are not well known. We have evaluated the results of revision using a modular cup with hydroxyapatite grafting for Paprosky type 2 and 3 acetabular defects at a minimum of ten years’ follow-up. We retrospectively reviewed 49 acetabular revisions at a mean of 135 months (120 to 178). There was one type 2B, ten 2C, 28 3A and ten 3B hips. With loosening as the endpoint, the survival rate was 74.2% (95% confidence interval 58.3 to 90.1). Radiologically, four of the type 3A hips (14%) and six of the type 3B hips (60%) showed aseptic loosening with collapse of the hydroxyapatite layer, whereas no loosening occurred in type 2 hips. There was consolidation of the hydroxyapatite layer in 33 hips (66%). Loosening was detected in nine of 29 hips (31%) without cement and in one of 20 hips (5%) with cement (p = 0.03, Fisher’s exact probability test). The linear wear and annual wear rate did not correlate with loosening. These results suggest that the long-term results of hydroxyapatite grafting with cement for type 2 and 3A hips are encouraging

Aims. There is a lack of biomaterial-based carriers for the local delivery of rifampicin (RIF), one of the cornerstone second defence antibiotics for bone infections. RIF is also known for causing rapid development of antibiotic resistance when given as monotherapy. This in vitro study evaluated a clinically used biphasic calcium sulphate/hydroxyapatite (CaS/HA) biomaterial as a carrier for dual delivery of RIF with vancomycin (VAN) or gentamicin (GEN). Methods. The CaS/HA composites containing RIF/GEN/VAN, either alone or in combination, were first prepared and their injectability, setting time, and antibiotic elution profiles were assessed. Using a continuous disk diffusion assay, the antibacterial behaviour of the material was tested on both planktonic and biofilm-embedded forms of standard and clinical strains of Staphylococcus aureus for 28 days. Development of bacterial resistance to RIF was determined by exposing the biofilm-embedded bacteria continuously to released fractions of antibiotics from CaS/HA-antibiotic composites. Results. Following the addition of RIF to CaS/HA-VAN/GEN, adequate injectability and setting of the CaS/HA composites were noted. Sustained release of RIF above the minimum inhibitory concentrations of S. aureus was observed until study endpoint (day 35). Only combinations of CaS/HA-VAN/GEN + RIF exhibited antibacterial and antibiofilm effects yielding no viable bacteria at study endpoint. The S. aureus strains developed resistance to RIF when biofilms were subjected to CaS/HA-RIF alone but not with CaS/HA-VAN/GEN + RIF. Conclusion. Our in vitro results indicate that biphasic CaS/HA loaded with VAN or GEN could be used as a carrier for RIF for local delivery in clinically demanding bone infections. Cite this article: Bone Joint Res 2022;11(11):787–802

Aims. The primary aim of this study is to assess the survival of the uncemented hydroxyapatite (HA) coated Trident II acetabular component as part of a hybrid total hip arthroplasty (THA) using a cemented Exeter stem. The secondary aims are to assess the complications, joint-specific function, health-related quality of life, and radiological signs of loosening of the acetabular component. Methods. A single-centre, prospective cohort study of 125 implants will be undertaken. Patients undergoing hybrid THA at the study centre will be recruited. Inclusion criteria are patients suitable for the use of the uncemented acetabular component, aged 18 to 75 years, willing and able to comply with the study protocol, and provide informed consent. Exclusion criteria includes patients not meeting study inclusion criteria, inadequate bone stock to support fixation of the prosthesis, a BMI > 40 kg/m. 2. , or THA performed for pain relief in those with severely restricted mobility. Results. Implant survival, complications, functional outcomes and radiological assessment up to ten years following index THA (one, two, five, seven, and ten years) will be performed. Functional assessment will include the Oxford Hip Score, Forgotten Joint Score, 12-Item Short Form Health Survey, EuroQol five-dimension health questionnaire, and pain and patient satisfaction. Radiological assessment with assess for acetabula lucent lines, lysis, and loosening according to DeLee and Charnley zones. Conclusion. This study is part of a stepwise introduction of a new device to orthopaedic practice, and careful monitoring of implants should be carried out as part of the Beyond Compliance principles. The results of this study will provide functional, radiological, and survival data to either support the ongoing use of the HA acetabulum or highlight potential limitations of this new implant before wide adoption. Cite this article: Bone Jt Open 2023;4(10):782–790

Bone is a dynamic tissue with a quarter of the trabecular and a fifth of the cortical bone being replaced continuously each year in a complex process that continues throughout an individual’s lifetime. Bone has an important role in homeostasis of minerals with non-stoichiometric hydroxyapatite bone mineral forming the inorganic phase of bone. Due to its crystal structure and chemistry, hydroxyapatite (HA) and related apatites have a remarkable ability to bind molecules. This review article describes the accretion of trace elements in bone mineral giving a historical perspective. Implanted HA particles of synthetic origin have proved to be an efficient recruiting moiety for systemically circulating drugs which can locally biomodulate the material and lead to a therapeutic effect. Bone mineral and apatite however also act as a waste dump for trace elements and drugs, which significantly affects the environment and human health. Cite this article: Bone Joint Res 2020;9(10):709–718

Abstract. INTRODUCTION. Polyetheretherketone (PEEK) is a high-performance thermoplastic polymer which has found increasing application in orthopaedic implant devices and has a lot of promise for ‘made-to-measure’ implants produced through additive manufacturing [1]. However, a key limitation of PEEK is that it is bioinert and there is a requirement to functionalise its surface to make the material osteoconductive to ensure a more rapid, improved and stable fixation, in vivo. One approach to solving this issue is to modify PEEK with bioactive materials, such as hydroxyapatite (HA). OBJECTIVE. To 3D PEEK/HA composite materials using a Fused Filament Fabrication (FFF) approach to enhance the properties of the PEEK matrix. METHODS. PEEK/HA composites (0–30% w/w HA/PEEK) were 3D printed using a modified Ultimaker 2+ 3D printer. The mechanical, thermal, physical, chemical and in vitro properties of the 3D printed samples were all studied as part of this work. RESULTS. The CT images of both the filament and the 3D printed samples showed that the HA material was evenly dispersed throughout the bulk all the samples. SEM/EDX measurements highlighted that HA was homogenously distributed across the surface. As the HA content of the samples increases, so does the tensile modulus, ranging from 4.2 GPa (PEEK) to 6.1 GPa (30% HA/PEEK) and are significantly higher than datasheet information of injected molded PEEK samples. All materials supported the growth of osteoblast cells on their surface. CONCLUSIONS. The results clearly show that we can successfully and easily 3D print HA/PEEK composite materials up to 30% w/w HA/PEEK. The samples produced have a homogeneous distribution of HA in both the bulk and surface of all the samples, and their mechanical performance of the PEEK is enhanced by the addition of HA

Abstract. Objectives. The objective of this study is to investigate the effect of solvents and rheological properties of PCL/Hydroxyapatite ink on the shape fidelity of the 3D printed scaffolds for bone tissue engineering. Methods. A series of inks were made consisting of 50% (w/v) of polycaprolactone (PCL) filled with 0%, 3.5% and 12.5% (w/V) of hydroxyapatite (HA) in dichloromethane (DCM) and chloroform (CHF). Steady and oscillatory shear rheological tests were performed on a rheometer (Discovery HR-3). Solvent-cast direct ink writing was performed with a custom-made 3D printer for the fabrication of PCL/HA scaffold structures with 2–8 layers. Optical microscope and scanning electron microscopy (SEM) were used to assess the shape fidelity. Results. Shape fidelity of the inks was quantitively assessed on the 3D printed scaffold structures allowing subjective comparisons. The addition of HA particles increased zero-shear viscosity by up to 900%. For oscillatory tests, plateau of storage modulus was observed in the low-frequency region which is attributed to good dispersion of the HA particles inside the matrix that leads to the formation of filler networks, resulting in pseudo-solid behavior and shape fidelity improvement. As the HA concentration increases, the plateau becomes more pronounced and the shape fidelity increases. With the same concentration, all DCM inks also show higher viscosity (from 10% to 200%) and better shape fidelity than CHF inks. As DCM has a lower boiling point (39.6 °C) than CHF (61.2°C), DCM evaporates quicker reducing the fusion and diffusion of deposited ink filaments before solidification which is observed in SEM images. Conclusions. This study reveals insights into using rheological characterizations as a tool for evaluation of shape fidelity of solvent-based DIW inks and also provides fundamental information on the influence of different solvents on the fidelity of 3D printed scaffolds. Declaration of Interest. (b) declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported:I declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project

Carbonate-substituted hydroxyapatite (CHA) is more osteoconductive and more resorbable than hydroxyapatite (HA), but the underlying mode of its action is unclear. We hypothesised that increased resorption of the ceramic by osteoclasts might subsequently upregulate osteoblasts by a coupling mechanism, and sought to test this in a large animal model. Defects were created in both the lateral femoral condyles of 12 adult sheep. Six were implanted with CHA granules bilaterally, and six with HA. Six of the animals in each group received the bisphosphonate zoledronate (0.05 mg/kg), which inhibits the function of osteoclasts, intra-operatively. After six weeks bony ingrowth was greater in the CHA implants than in HA, but not in the animals given zoledronate. Functional osteoclasts are necessary for the enhanced osteoconduction seen in CHA compared with HA

Osseointegration has been shown to be directly affected by surface roughness and bioactive coatings. This report compares bone response to hydroxyapatite coatings on differing substrate treatments. Titanium cylinders was implanted bilaterally in the distal femora of 30 rabbits. One of three surface treatments was applied to each implant: plasma sprayed titanium surface without hydroxyapatite coating (P), plasma sprayed titanium surface with hydroxyapatite coating (PHA), and acid-etched surface with hydroxyapatite coating (CHA). Osseointegration was measured at 6 and 12 weeks, by histomorphometry of scanning electron microscopy images of histologic sections taken through the implant at three levels: diaphysis, metaphysis, and intermediate. Bone growth was measured up to 3 mm from the edge of the implant to determine changes in patterns of bone growth. Overall, bone response was greatest in the diaphyseal sections. Mean osseointegration was significantly different between hydroxyapatite coated and non-hydroxyapatite coated implants (CHA: 74+10%, PHA: 65+12%, and P: 39+10%, p< 0.01). Both hydroxyapatite coated implants demonstrated increased bone growth closer to the implant which dropped off with increasing distance from the implant. Lower and relatively unchanging levels of bone growth were seen in non-hydroxyapatite coated implants. Osseointegration and bone growth was higher in both hydroxyapatite coated surfaces confirming previous reports. The differences in substrates (acid etched vs. plasma sprayed titanium) did not yield a significant difference in bone growth, suggesting that the hydroxyapatite coating provided a much larger benefit. This study supports the hypothesis that enhanced osseointegration is primarily due to the bioactive coating

The aseptic loss of bone after hip replacement is a serious problem leading to implant instability. Hydroxyapatite coating of joint replacement components produces a bond with bone and helps to reduce loosening. However, over time bone remodeling at the implant interface leads to loss of hydroxyapatite. One possible solution would be to develop a coating that reduces hydroxyapatite and bone loss. Hydroxyapatite can be chemically modified through the substitution of ions to alter the biological response. Zinc is an essential trace element that has been found to inhibit osteoclast-like cell formation and decrease bone resorption. It was hoped that by substituting zinc into the hydroxyapatite lattice, the resultant zinc-substituted hydroxyapatite (ZnHA) would inhibit ceramic resorption and the resorption of bone. The aim of this work was to investigate the effect of ZnHA on the number and activity of osteoclasts. Discs of phase pure hydroxyapatite (PPHA), 0.37wt% ZnHA and 0.58wt% ZnHA were produced, sintered at 1100 degrees Celsius and ground with 1200 grit silicon carbide paper. They were cultured in medium containing macrophage colony stimulating factor and receptor activator of nuclear factor kappa B ligand (RANKL) for 11 and 21 days. A control disc of PPHA cultured in medium containing no RANKL was also used. On the required dates the discs were removed and the cells stained for actin with phalloidin-TRITC and the cell nuclei with 4',6-Diamidino-2-phenylindole dihydrochloride. Cells with 3 or more nuclei were classed as osteoclasts and counted using ImageJ. On day 21 after the cells had been counted, the cells were removed and the discs coated in platinum before viewing with a scanning electron microscope. Resorption areas were then measured using ImageJ. The addition of zinc was observed to significantly decrease the number of differentiated osteoclasts after 21 days (p<0.005 for 0.58wt% ZnHA compared to PPHA and p<0.01 for 0.37wt% ZnHA compared to PPHA). The area of resorption was also significantly decreased with the addition of zinc (p<0.005 for the comparison of 0.58wt% ZnHA with PPHA). The work found that zinc substituted hydroxyapatite reduced the number and subsequent activity of osteoclasts

Two calcium phosphate cements, brushite and hydroxyapatite, have been recently developed as bone substitution materials. The brushite cement is biocompatible, resorbable, osteoconductive and injectable since it hardens in physiological conditions. In contrast, hydroxyapatite is less resorbable and is not injectable. However, hydroxyapatite presents a higher strength, which may open the perspective of use in weight-bearing regions of the skeleton subjected to multi-axial stresses. The purpose of this work is a full characterization of the multiaxial elastic and failure behaviour of these two cements in a moist environment. The brushite cement was prepared by mixing three phosphate powders in presence of water. A mixture of monetite and calcite powders in presence of water was used to obtain hydroxyapatite self-setting cement. Cylindrical, hollow specimens (Øext=18mm, Øint=14mm, L=40mm) were manufactured to apply uniaxial and torsional deformations. The specimens were cast with a custom mould, avoiding any machining, and thus, residual stresses. Scanning electron microscopy and x-ray diffraction were used to examine the cement microstructures and to determine their final material phases. An MTS axial-torsional machine was used for all mechanical tests. Compression, tension and torsion tests were performed each on five brushite and five hydroxyapatite specimens under moist conditions. Uniaxial and biaxial extensometers were used to measure the elastic moduli and the Poisson ratio. The brushite cement exhibited failure properties comparable or below those of average human cancellous bone and confirmed its indication as a bone filling material (Brushite failure strength : 1.3±0.3 MPa in tension, 2.9±0.4 MPa in shear and 10.7±2.0 MPa in compression). The hydroxyapatite cement had an order of magnitude larger compressive strength (75±4.2 MPa), comparable tensile (3.5±0.9 MPa) and shear (4.8±0.3 MPa) strengths as average human cancellous bone. As expected, the latter cement seems to be more compatible with a multiaxial weight-bearing function in bone substitution

The feasibility of bone transport with bone substitute and the factors which are essential for a successful bone transport are unknown. We studied six groups of 12 Japanese white rabbits. Groups A to D received cylindrical autologous bone segments and groups E and F hydroxyapatite prostheses. The periosteum was preserved in group A so that its segments had a blood supply, cells, proteins and scaffold. Group B had no blood supply. Group C had proteins and scaffold and group D had only scaffold. Group E received hydroxyapatite loaded with recombinant human bone morphogenetic protein-2 and group F had hydroxyapatite alone. Distraction osteogenesis occurred in groups A to C and E which had osteo-conductive transport segments loaded with osteo-inductive proteins. We conclude that scaffold and proteins are essential for successful bone transport, and that bone substitute can be used to regenerate bone

Introduction: Polyethylene wear debris is the main contributing factor that leads to aseptic loosening and osteolysis. The main objective of this study was to evaluate the role of hydroxyapatite (HA) in third-body polyethylene wear in total hip arthroplasty. Materials: 199 primary cementless THA’s (174 patients) performed by a single surgeon were enrolled in a prospective randomized study comprising hydroxyapatite and non-hydroxyapatite coated femoral implants. The femoral component had metaphyseal-diaphyseal fit design with proximal plasma sprayed titanium circumferential porous coating. The hydroxyapatite coating was 50 – 75 micrometers over the porous surface with the components of identical design. The acetabular component was plasma sprayed titanium porous coated shell without hydroxyapatite. T he polyethylene liners were machined molded from ram extruded Hi-fax 1900H polyethylene resin gamma-sterilized in argon (inert) gas. Clinical and Radiographic evaluation was performed employing HSS scores and Engh criteria. Results: At a mean follow-up of 5 years, the radiographs of 83 HA and 73 Non-HA hips were evaluated by two independent observers utilizing computer-assisted wear analysis on digitized standardized radiographs described by Martell et al (1997). The radiographs were also evaluated for osteolysis or aseptic loosening. The mean linear wear rate in HA group was 0.19mm/yr and in the non-HA group was 0.21mm/yr, which was not significant (p> 0.05). There was no case of osteolysis or aseptic loosening of any component. Both groups had comparable outcomes in terms of HSS scores, walking ability and sports participation. Discussion: This study has attempted to demonstrate through an appropriately controlled in vivo study that hydroxyapatite does not play a significant role in third-body polyethylene wear in THA at a mean follow-up of five years. The concern of three-body wear with hydroxyapatite coating is no greater than porous coated cementless implants

Aim. Treatment principles of chronic osteomyelitis include debridement, clean sampling, excision of dead bone, stabilization, dead space management, soft tissue closure and systemic antibiotic therapy. Dead space management becomes very complicated, if the bone infection is caused by multi-resistant bacteria. The aim of this investigation was to evaluate the effect of a new vancomycin-loaded hydroxyapatite / calcium sulfate composite. *. in the treatment of chronic osteomyelitis (OM) caused by multi-resistant bacteria. Method. From June 2015 to November 2015, 7 patients (4 males, 3 females, average age 52.6y) were treated according to the above mentioned principles using the new vancomycin-loaded hydroxyapatite / calcium sulfate composite. *. Infections were caused by methicillin-resistant Staphylococcus aureus (MRSA), multi-resistant Staphylococcus epidermidis (MRSE) and polymicrobial, vancomycin-sensitive bacteria. We used a two-stage protocol with debridement, excision of bone and external stabilization in the first stage, followed by bone defect reconstruction. To fill the residual bone defects, in 3 patients the new vancomycin-loaded hydroxyapatite / calcium sulfate composite. *. (10mL) was used on its own and in 4 patients combined with 18mL of an unloaded calcium sulfate / hydroxyapatite composite. **. Post-operative follow-up was evaluated clinically and by radiographs and CT scans at 6, 14 and 24 weeks. Results. In 6 of 7 patients rapid control of infection was achieved. Soft tissue reactions and prolonged white wound drainage (caused by calcium sulfate dissolution) was seen in 3 of 7 patients. In 6 of 7 patients recurrence of infection has not been observed so far. Radiographs showed different elution intervals of the radiocontrast agent (Iohexol), depending on anatomical location. Bone remodelling or replacement of the composite by new bone was not uniform in the patients and showed specific radiographic signs. In addition to the so-called „puddle sign“, we found septae, membranes, vacuoles and sometimes arc-like structures. Therefore, we suggest the name “arc-sign” for these formations. Conclusions. During the follow-up of the first 7 patients treated with the unloaded calcium sulfate / hydroxyapatite composite. **. in 6 of 7 cases no recurrence of infection was observed. This is very promising in the difficult situation of bone infections caused by multi-resistant bacteria. Follow-up radiographs and CT-scans showed specific patterns during the resorption of the composite and the formation of new bone, which have not been described in other bone graft substitutes so far. The bone defects are not completely filled yet, but the affected bones are clinically stable and patients can ambulate with full weight bearing

A longitudinal study was done assessing the latest radiographs available in a series of collarless Corail uncemented stems which have reported survival rates of 95% at 20 years. Parameters scored included the degree of “Ghosting” or delamination, the Gruen, the stem fit in the femoral canal and the degree of calcar resorption. Patient and implant demographics were noted. At 3 years the loosening rate was 23% reaching 64% at 6 years after the index procedure. It was present in all age groups, with a peak in the 24 to 49 year age group. Males and females had the same occurrence. When it was present this was always in zone 1. It was present in 6% of patients in zone 7, but then always associated with zone 1 changes. High and standard off-set stems had the same loosening rates. The looser fit of the stem the higher the incidence of loosening. There was no correlation to the type of bearing surface or the degree of calcar resorption. Those patients with a BMI of 25 – 35 had lower loosening rates compared to those with higher or lower BMI's. We postulate that cancellous bone on-growth onto the hydroxyapatite coating associated with loading flexural micro-motion leads to hydroxyapatite being pulled off the smooth stem substrate in zone 1. Progressive delamination of the hydroxyapatite then occurs. The triple-tapered design though imparts continued stability. We report high loosening rates in the Corail stem and suggest a mechanism for its development

Introduction: The aetiology of dystrophic disc calcification in adult humans is unknown but a well-described clinical disorder with hydroxyapatite as the single mineral phase. Comparable but age-related pathology in the sheep could serve as a model for the human disorder. The objective of this study was to investigate the mineral phase, its mechanisms of formation/association with degeneration in a naturally-occurring animal model of disc calcification. Methods: Adult sheep lumbar intervertebral discs (n=134) from animals aged 6 (n=4), 8 (n=12) and 11 years (n=2) were evaluated using radiography, morphology, scanning and transmission electron microscopy, energy dispersive X-ray spectroscopy, X-ray powder diffraction, histology, immunohistology and proteoglycan analysis. Results: Half of the 6 yr, 84% of the 8 yr and 86% of the 11 yr old discs had calcific deposits. These were not well delineated by plain radiography. They were either:. punctate deposits in the outer annulus,. diffuse deposits in the transitional zone or inner annulus fibrosus with occasional deposits in the nucleus, or. large deposits in the transitional zone extending variably into the nucleus. Their maximal incidence was in the lower lumbar discs (L4/5-L6/7) with no calcification seen in the lumbosacral or lower thoracic discs. All deposits were hydroxyapatite with large crystallite sizes (800–1300 angstrom) compared to cortical bone (300–600 angstrom). No type X-collagen, osteopontin or osteonectin, were detected in calcific deposits although positive staining for bone sialoprotein was evident. Calcified discs had less proteoglycan of smaller hydrodynamic size than non-calcified discs. Discussion: Disc calcification in ageing sheep is due to hydroxyapatite deposition. The variable but large crystal size, lack of protein markers indicate that this does not occur by an ordered endochondral ossification-like process. The decrease in disc proteoglycan content and size suggests an association between calcification and disc degeneration in ageing sheep. There are notable dissimilarities between hydroxyapatite deposition disorder in humans and sheep. No mechanistic explanation can be offered for the different spinal distributions, thoracic and upper lumbar in the former and lumbar in the latter; hydroxyapatite deposition disorder has occasionally been seen in the lumbar spines of four year old sheep during the course of other studies but not at an earlier age. Diffferences in spinal biomechanics may be implicated but hydroxyapatite deposition does not primarily affect the most or least mobile discs in either species. Neither can an explanation be offered for the apparent immunity of the ovine lumbosacral disc to calcification. However, it is known that proteoglycan turnover is faster at this spinal level than at more proximal lumbar discs. While we have been unable to elucidate the mechanism of hydroxyapatite deposition disorder in sheep, clearly it is different from that in normal osteogenesis. We contend this animal provides a useful, naturally-occurring model for investigation of the aetiology and pathogenesis of human hydroxyapatite deposition disorder, notwithstanding obvious differences between sheep and man

In revision THA, the solid acetabular reconstruction in the true acetabulum is often challenging. We are using the Kerboull acetabular reinforcement devices after packing hydroxyapatite granules for acetabular bone defects. We report our 3–7 year clinical and roentgenographical results. Twenty-one acetabuli in 20 patients were reconstructed in the true acetabuli with Kerboull-type acetabular reinforcement devices and porous hydroxyapatite granules (Sumitomo Pharmaceutical Co. Ltd.). The mean age of the patients at operation was 68 years. The mean follow-up period was 5 years and 3 months (38–88 months). Acetabular bone deficiencies were evaluated according to AAOS classification (type II: 5 hips, type III: 16 hips). Porous hydroxyapatite granules (20–60 grams) were grafted to all the acetabuli. Autologous cortico-cancellous bone grafts or hydroxyapatite blocks were used to reconstruct the segmental defects in 6 hips. All the acetabuli were reinforced with Ker-boull-type reinforcement devices and Charnley-type cemented prostheses were implanted. Clinical and roent-genographical results were evaluated using Japanese Orthopaedic Association hip score and Hodgkinson classification. Average hip score was improved from 42 points to 75 points. No re-revision was done. No infection was noted. The roentgenograms showed neither migration nor loosening of the acetabular components. Porous hydroxyapatite granules are one of the best bone substitutes because of their mechanical and biochemical properties. Oonishi reported very good results of his acetabular reconstruction using this material. The Kerboull-type acetabular devices are very effective to the reconstruction in the true acetabulum. Excellent results of these devices were reported by Kerboull. Ace-tabular reconstrution using both of them showed very good clinical and roentgenographical results during 3 to 7 post-operative years in our series

Sixty-two consecutive primary total hip arthroplasties were prospectively randomized to receive either hydroxyapatite coated (thirty-five hips) or nonhydroxy-apatite coated (twenty-seven hips) femoral prostheses. At a minimum eleven-year followup fifty-one hips (forty-four patients) were evaluated. Only one femoral stem had been revised (secondary to traumatic periprosthetic fracture). Radiographs were available for thirty-nine hips. None of these femoral stems were loose. Harris Hip scores were evaluated for thirty-six unrevised hips and did not differ significantly between the two groups. There appears to be no significant advantage to hydroxyapatite coating for this femoral prosthesis at an average follow-up of thirteen years. There are a paucity of long term randomized controlled trials on results of hydroxapatite coating of femoral prostheses. The purpose of this study was to update the results of a prospective randomized study of a proximally pourous coated, tapered titanium femoral component with and without hydroxyapatite coating. Sixty-two consecutive primary total hip arthroplasties done by one surgeon in fifty-five patients were prospectively randomized to receive either hydroxyapatite coated (thirty-five hips) or nonhydroxyapatite coated (twenty-seven hips) femoral prostheses. At a minimum eleven year followup, three hips (three patients) were lost to followup, and a further eight patients had expired (eight hips). The remaining surviving cohort of fifty-one hips (forty-four patients) were evaluated clinically, including Harris Hip Scores, and radiographically. At an average of thirteen years followup, only one femoral stem had been revised (secondary to traumatic periprosthetic fracture), that being in the hydroxyapatite group. There were eight acetabular revisions in the hydroxyapatite group (thirty-four percent) and four acetabular revisions in the nonhydroxyapatite group (sixteen percent). Radiographs were available for thirty-nine hips. None of these femoral stems were loose. Harris Hip scores were evaluated for thirty-six unrevised hips and did not differ significantly between the two groups. Using endpoints of femoral revision, radiographic loosening, and Harris Hip Scores there appears to be no significant advantage to hydroxyapatite coating for this femoral prosthesis at an average follow-up of thirteen years. Funding: Biomet, Warsaw IN

Introduction: Polyethylene wear debris is the main contributing factor that leads to aseptic loosening and osteolysis. The main objective of this study was to evaluate the role of hydroxyapatite (HA) in third-body polyethylene wear in total hip arthroplasty. Materials: 199 primary cementless THA’s (174 patients) performed by a single surgeon were enrolled in a prospective randomized study comprising Hydroxyapatite and non-hydroxyapatite coated femoral implants. The femoral component had metaphyseal-diaphyseal fit design with proximal plasma sprayed titanium circumferential porous coating. The hydroxyapatite coating was 50 – 75 micrometers over the porous surface with the components of identical design. The acetabular component was plasma sprayed titanium porous coated shell without hydroxyapatite

Surgical failure, mainly caused by loosening implants, causes great mental and physical trauma to patients. Improving the physicochemical properties of implants to achieve favourable osseointegration will continue to be the focus of future research. Strontium (Sr), a trace element, is often incorporated into hydroxyapatite (HA) to improve its osteogenic activity. Our previous studies have shown that miR-21 can promote the osteogenic differentiation of mesenchymal stem cells by the PI3K/β-catenin pathway. The aim of this study is to fabricate a SrHA and miR-21 composite coating and it is expected to have a favorable bone healing capability. Ti discs (20 mm diameter and one mm thickness for the in vitro section) and rods (four mm diameter and seven mm length for the in vivo section) were prepared by machining pure Ti. The Ti cylinders were placed in a Teflon-lined stainless-steel autoclave for treating at 150°C for 24 h to form SrHA layer. The miR-21 was encapsulated in nanocapsules. The miR-21 nanocapsules were mixed with CMCS powder to form a gel-like sample and uniformly coated on the SrHA modifed Ti. Osteoblast-like MG63 cells were cultured on SrHA and miR-21 modified Ti, Cell proliferation activity and osteogenesis-related gene expression were evaluated. A bone defect model was established with mature New Zealand to evaluate the osseointegration. Cylindrical holes (four mm in diameter) were created at the distal femur and tibial plateau. Each rabbit was implanted with four of the aforementioned rods (distal femur and tibial plateau of the hind legs). After implantation for one, two and three months, the rabbits were observed by X-ray and scanned using u-CT. Histological and Immunohistochemical analysis were performed to examine the osteogenic markers. A biomechanical push-in test was used to assess the bone-implant bonding strength. Both SrHA nanoparticles with good superhydrophilicity and miR-21 nanocapsules with uniform sizes were distributed evenly on the surface of the Ti. In vitro experiments revealed that the composite coating was beneficial to osteoblast proliferation, differentiation and mineralization. In vivo evaluations demonstrated that this coating could not only promote the expression of angiogenic factor CD31 but also enhance the expression of osteoblastic genes to facilitate angio-osteogenesis. In addition, the composite coating also showed a decreased RANKL expression compared with the miR-21 coating. As a result, the SrHA/miR-21 composite coating promoted new bone formation and mineralization and thus enhanced osseointegration and bone-implant bonding strength. A homogeneous SrHA and miR-21 composite coating was fabricated by generating pure Ti through a hydrothermal process, followed by adhering miR-21 nanocapsules. This coating combined the favorable physicochemical properties of SrHA and miR-21 that synergistically promoted angiogenesis, osteogenesis, osseointegration, bone mineralization and thus bone-implant bonding strength. This study provided a new strategy for surface modification of biomedical implants

The aim of this study was to evaluate the trochlear bone and cartilaginous regeneration of rabbits using a composite based on platelet rich plasma (PRP), chitosan and hydroxyapatite. The study was approved by the ethics committee of the Federal University of Campina Grande under number 72/2017. Surgical holes measuring four millimetres in diameter were performed in rabbit trochleae, one surgical hole in each animal remained empty and another one was filled with the composite. Clinical-orthopaedic and radiographic evaluations were carried out for 60 days, after which the animals were euthanized for histomorphometric evaluations. Clinical-evaluations exhibited lameness of two members of the treatment (T) group and one member of control (C) group. The radiographic evaluation of T group exhibited absence of subchondral bone reaction (33%); nonetheless, presence of moderate subchondral bone reaction was more frequently reported in group C with 67%. Microscopic evaluation revealed the presence of tissue neoformation, composed of dense connective tissue. Microscopic findings were similar in both groups, with a difference in the amount of neoformed tissue, which was confirmed after the morphometric analysis, revealing a significant difference in the quantity of newly formed tissue at the bone / cartilage / implant interface in the T group. The results indicate that the composite based on chitosan, hydroxyapatite and PRP enhanced bone and cartilage healing

Aims. Hydroxyapatite (HA)-coated collars have been shown to reduce aseptic loosening of massive endoprostheses following primary surgery. Limited information exists about their effectiveness in revision surgery. The aim of this study was to radiologically assess osteointegration to HA-coated collars of cemented massive endoprostheses following revision surgery. Methods. Retrospective review of osseointegration frequency, pattern, and timing to a specific HA-coated collar on massive endoprostheses used in revision surgery at our tertiary referral centre between 2010 to 2017 was undertaken. Osseointegration was radiologically classified on cases with a minimum follow-up of six months. Results. In all, 39 patients underwent radiological review at mean 43.5 months; 22/39 (56.4%) showed no osseointegration to the collar. Revision endoprostheses for aseptic loosening were less likely to show osseointegration compared with other indications for revision. Oncological cases with previous or current infection were more likely to show osseointegration to ≥ 1 collar side than those without evidence of prior infection. Conclusion. This seven-year review identified osseointegration of HA-coated collars after revision surgery is less likely (43.6%, 17/39) than after primary surgery. Young patients who undergo revision surgery following initial oncological indication may benefit the most from this collar design. Use in revision oncological cases with a history of infection may be beneficial. HA-coated collars showed limited benefit for patients undergoing revision for failed arthroplasty with history of infection. Cite this article: Bone Jt Open 2021;2(6):371–379

Aims: To investigate if coralline hydroxyapatite conduct bone formation in human spine. Methods: During revision surgery specimens were taken from the fusion mass from 13 patients, who received spinal instrumentation (Titanium alloy) and fusion with coralline hydroxyapatite. The age of patients at the time of revision surgery was 46±20 years. The time lapsed from the implantation of coralline hydroxyapatite (ProOsteon) was 11±11 months. The indication for revision was infection, pseudarthrosis, technical error, and pain related to hardware. The diagnosis for primary fusion was degenerative disease, spinal trauma and scoliosis. Coralline hydroxyapatite was applied on the posterior decorticated elements of the instrumented spine without any mixture with bone graft. Material from ten different places from the fusion mass was intraoperatively taken and the histological evaluation was made using the Hematoxylin-eosin histological stain. Results: There was a concentration of foreign-body like giant cells & development inflammatory granulomatous tissue around hydroxyapatite granules, which was gradually replaced by dense connective collagen tissue. Both inflammatory granulomatous and collagen tissue showed areas with foreign body reaction. In the cases, where bone has developed, the most initial finding was the presence of osteoblasts & apposition of osteoid in contact to hydroxyapatite granules. In a later phase, cancellous and lamellar bone has developed as a result of secondary ossification. Bone formation was observed in 11/15 cases. Conclusion: Coralline hydroxy-apatite conducts bone and osteoid formation around the implanted coralline hydroxyapatite granules in different areas of the human spine operated for different disorders

Bone fractures are highly observed clinical situation in orthopaedic treatments. In some cases, there might be non-union problems. Therefore, recent studies have focused on tissue engineering applications as alternative methods to replace surgical procedures. Various biopolymer based scaffolds are produced using different fabrication techniques for bone tissue engineering applications. In this study, hydroxyapatite (HAp) and loofah containing carboxymethyl chitosan (CMC) scaffolds were prepared. In this regard, first 4 ml of CMC solution, 0.02 g of hydroxyapatite (HAP) and 0.06 g of poly (ethylene glycol) diglycidyl ether (PEGDE) were mixed in an ultrasonic bath until the HAp powders were suspended. Next, 0.04 g of loofah was added to the suspension and with the help of PEGDE as the cross-linking agent, then, the mixture was allowed to cross-link at 40. o. C overnight. Finally, the three-dimensional, porous and sponge-like scaffolds were obtained after lyophilization (TELSTAR - LyoQuest −85) at 0.1 mbar and −25°C for 2 days. Morphologies, chemical structures and thermal properties of the scaffolds were characterized by scanning electron microscopy (SEM), Fourier Transform infrared spectroscopy (FT-IR) and thermogravimetric differential thermal analysis (TGA/DTA), respectively. In addition, swelling behavior and mechanical properties of the scaffolds under compression loading were determined. In order to investigate biocompatibility of the scaffolds, WST-1 colorimetric assay at days 0, 1, 3, 5 and 7 was conducted by using human dermal fibroblast. Also, histological and morphological analysis were performed for cell attachment at day 7. In conclusion, the produced scaffolds showed no cytotoxic effect. Therefore, they can be considered as a candidate scaffold for bone tissue regeneration. Further studies will be performed by using bone marrow and periosteum derived mesenchymal stem cells with these scaffolds

Objective: To determine if a porous, coralline-derived hydroxyapatite block (ProOsteon 500. TM. , Interpore, Irvine, CA) is a suitable substitute for tricortical iliac crest autograft in cervical interbody fusion. Design: A prospective randomised trial with two-year follow-up comparing clinical and radiographic outcomes in patients receiving either iliac crest or hydroxyapatite grafts in cervical interbody fusion. Subjects: Twenty-nine patients undergoing cervical fusion and anterior plating were randomised to receive either iliac crest (Group I) or hydroxyapatite (Group II) interbody grafts. Fourteen patients (19 grafts) in Group I and twelve patients (18 grafts) in Group II were available for final analysis. Both groups were similar with respect to age, sex, diagnosis and levels fused. Outcome Measures: The SF-36 and Oswestry Disability Index were used to measure clinical outcome. Post-op and final follow-up radiographs were analysed for graft fragmentation, loss of height, loss of angular alignment and hardware failure to assess structural integrity of the graft. Computed or plain tomography was used to evaluate fusion. Results: Groups I and II demonstrated improvement in preoperative scores for bodily pain (p=. 016 and. 016 respectively) and physical functioning (p=. 050 and. 016 respectively) at final follow-up. There was no significant difference in SF-36 and Oswestry scores between the two groups. Successful radiographic fusion was similar in both groups (79% in Group I and 76% in Group II). Graft fragmentation occurred in 89% of the hydroxyapatite grafts and 11% of the autografts (p=. 001). Greater than 2mm of graft height and 3° of segmental lordosis were lost in 55% of hydroxyapatite grafts vs. 11% of autografts (p=. 009). One patient in Group II and none in Group I required revision surgery for graft failure. The high rate of early radiographic failure in the hydroxyapatite grafts prompted suspension of further enrolment in the clinical trial. Conclusions: ProOsteon 500 coralline hydroxyapatite blocks do not possess adequate structural integrity to resist axial loading and maintain disc height or segmental lordosis during cervical interbody fusion

Aim. Bone and implant-associated infections caused by microorganisms that grow in biofilm are difficult to treat because of persistence and recurrence. Systemic administration of antibiotics is often inefficient because the poor vascularization of the site of infection. This issue has led to the development of biomaterials capable to locally deliver high doses of therapeutic agents to the injured bone with minimal systemic effects. In this context, calcium sulphate/hydroxyapatite (CS/HA) bone graft substitutes are widely used being safe, osteoconductive and resorbable biomaterials that can be easily enriched with consistent amounts of antibiotics. In this in vitro study, the capability of the eluted antibiotics to select the tested bacterial strains for antibiotic resistance was evaluated to confirm the safe use of the product. Method. S. aureus, S. epidermidis and P. aeruginosa isolated in our Institute from bone and joint infection with different resistance phenotypes were used. 6 × 2.5 mm CS/HA discs were generated by pouring the antibiotic loaded formulations in a mold and were used as a modified disk diffusion test. The resistance selection was evaluated by subculturing cells growing on the edge of the zone of inhibition (ZOI) for seven days. Minimum inhibitory concentrations (MICs) of gentamicin and vancomycin were determined by broth microdilution method before and after the selection of resistance assay. In addition, MICs were assessed after seven day passage on antibiotic free agar plates to evaluate if eventual decrease of antibiotic susceptibility was stable or only transient. Results. Commonly, no adaptation in presence of both CS/HA formulations was observed by analysing ZOI on agar medium. The kinetic of decrease of the ZOI was similar between the strains, with the exception of gentamicin resistant staphylococci in presence of gentamicin loaded CS/HA, which was faster with respect to the susceptible strains. Conclusions. The present study shows that elution of gentamicin and vancomycin from CS/HA bone graft substitutes did not induce a decrease in susceptibility to these antibiotics in an in vitro setting, suggesting the safe use of the product

Aims: The bone – conductive proparties of hydroxyapatite (HA) coatings are attractive in revision surgery with bone loss. The purpose of this study is to analyse the clinical and radiological results of 55 cases of revision hip arthroplasty using hydroxyapatite femoral stems. Methods: Between May 1995 and October 2000 we performed 55 patients total hip replacements in 50 patients (5 bilateral) using hydroxyapatite (HA) – coated femoral stem. The average age of the patients at the time of the index revision was 67 years (range 44–84). Clinical evaluation was by a Merle d’Aubigne Score (preoperative 6.54 points). Radiological evaluation used the AAOS system for preoperative films and scaring system after Engh for the postoperative films. Bone grafts was required in 35 cases. Results: Postoperative Merle d’Aubigne score was 17.25 points. Complications: 3 dislocations, one transitory nerve palsy and 14 associated intraoperative fractures. All grafts consolidated. None of the femoral stem components required revision because of aseptic loosening. No radiologically progressive lucency or signs indicating a loose implant were visible in anycases. There were no cases of femoral stem migration. Conclusions: We conclude that the hydroxyapatite femoral stem is suitable for implantation at revision hip arthroplasty and can give good results in the short to medium term, because the clinical and radilogical results are excellent, with a early consolidate fractures

Purpose: Hinged knee prostheses are mainly used for reconstruction after major tumour resection. Aseptic loosening is the main problem with these implants. One of the solutions proposed to reduce the rate of loosening is to add a hydroxyapatite collar on the shaft stems. This work was conducted to study bone ingrowth with a new hinged implant with a hydroxyapatite collar at the junction between the zone of resection and the shaft. Material and methods: Twenty-nine massive prostheses with a hydroxyapatite collar were implanted between 1998 and 2001. Nine patients were excluded from the analysis because follow-up was less than two years. This retrospective analysis thus compared twenty massive prostheses with twenty matched hinged GUEPAR prostheses without a collar. Bony ingrowth was measured on plain x-rays (two orthogonal views) at 6, 12, 24, and 36 months. Filling of the gap between the bone and the implant was also assessed. Signs of loosening were noted. Results: Mean bony ingrowth in implants with a hydroxyapatite collar was 6.58 mm at 6 months 9.84 mm at 12 months, 12.3 mm at 24 months and 13.25 mm at 36 months. Mean bony ingrowth in the implants without a hydroxyapatite collar was 1.65 mm at 6 months, 3.31 mm at 12 months, 4.8 mm at 24 months and 4.35 mm at 36 months. In the implants with a collar, gap filling was partial in five cases and total in 15. In implants without a collar, there was no gap filling in eight cases, partial filling in two cases and total filling in fifteen cases. Discussion: Prostheses with a hydroxyapatite collar enable better radiological bony ingrowth than observed in implants without a hydroxyapatite collar. Gap filling is better for prostheses with a collar. There was no case of loosening at last follow-up for implants with a hydroxyapatite collar. Conclusion: In light of these results, shaft anchorage appears to be better with implants with a hydrosyapatite collar. Confirmation of improvement in clinical outcome and lower rate of aseptic loosening will require longer follow-up

Purpose: Despite excellent histological and biomechanical results proving the real efficacy of “biological” implant-bone fixation, use of hydroxyapatite surfacing, widely used for hip implants, remains largely unemployed for knee prostheses. We analysed our ten years experience with hydroxyapatite coated knee implants in a prospective study of 384 cases. Material and methods: Among the 384 prostheses, 361 were primary implantations, and 331 (92%) were still “in place” after ten years experience. Nineteen patients had died and only one (0.3%) was lost to follow-up; three patients were excluded from the analysis due to other major handicaps. There were five revision procedures including three (0.8%) related to deep infection and two (0.6%) to failure with loosening and pain. Mean age of the patients was 70.4 years (40–89). Indications were basically degenerative disease (91%), inflammatory rheumatoid disease (6.9%) and necrosis (1.7%). Results: Mean IKS score at five years minimal follow-up for primary surgery patients was 95.4 and 84.2 points for the overall knee score and the functional score respectively, giving 81.1% and 73.1% good and excellent results for the knee and functional score. Discussion: These clinical results compare well with the best studies reported on total knee arthroplasty with or without cement. Radiographically, we did not have any cases with evidence of an implant-bone interface problem, for femoral or tibial components with the exception of two knees (0.55%) with severe osteolysis and loosening leading to revision surgery. In addition, hydroxyapatite demonstrated its capacity to progressively fill bone-implant gaps over time, confirming the experimental work by Søballe. Cumulative survival was 96.6±0.0688% and 97.37 ± 0.0324% taking ablation and prosthesis-related failure as the endpoint respectively. Conclusion: These results allow renewed confidence in hydroxyapatite as a prosthesis fixation mode, for the knee as well as for the hip

The success of uncemented arthroplasty depends on the achievement and maintenance of implant stability. Despite the use of modern instrumentation to obtain an accurate implant fit during total knee replacement, small gaps often remain visible at the bone-prosthesis interface on high quality fluroscopically-assisted radiographs. Although the clinical significance of these gaps is unclear, their presence delays bony fixation of the implant. In uncemented total hip arthroplasty, hydroxyapatite costing has been used to enhance early stability of the implant: bony apposition has been shown to occur rapidly even in the presence of a small gap between the implant and the bone. In addition, recent RSA (Radio-stereo-photogrammateric analysis) studies have shown reduced micromotion and enhanced implant stability with hydroxyapatite coating of both hip and knee prostheses. The following study was designed to observe and investigate the phenomenon of ‘gap-healing’ around hydroxyapatite coated uncemented total knee prostheses. Over a 15-month period a hydroxyapatite coated uncemented total knee prosthesis was implanted in 99 patients undergoing 108 primary knee arthroplasties. The patients were prospectively reviewed at regular intervals with an average follow up of 18 months and a minimum of 12 months. The implant-bone interface was evaluated by obtaining serial fluroscopically-assisted radiographs. On the immediate postoperative radiographs, small gaps between the implant and bone were seen in most knee. These gaps were visible on average in 2.16 AKS (American Knee Society)zones per knee. Most of the gaps were seen in Femoral zones 2,3,5 and Tibial zones 1 & 4. The majority of the gaps were under 1mm depth. Gaps> 2mm were seen only in 6 patients. Healing of the gaps was first seen at 3 months postoperatively, the average number of zones involved per knee dropping to 1.54. There was good evidence of ‘gap healing’ occurring at all the bone-implant interface zones. At the end of the first postoperative year, only 0.8 zones per knee were involved.2mm gaps remained visible in 3 patients. In animal experiments, hydroxyapatitie coated porous surfaces have shown an increased the rate of bone ingrowth for as many as 52 weeks after implantation. In our study, progressive bone ingrowth and gap-healing has been observed beyond this period, the average involved zones on 2 –year radiographs being 0.4 per knee. During the study period, the American knee score improved from 39.52 preoperatively to 89.97 at 1 year postoperatively. No relation was found between the clinical scores and the presence or absence of gaps on follow-up radiographs. This study demonstrates the phenomenon of ‘gap-healing’ following uncemented hydroxyapatitie coated primary total knee arthroplasty in an unselected group of patients. Gaps under 1 mm at the implant –bone interface heal readily. Healing of gaps> 2mm is less predictable

Introduction and Aims: Titanium foam implants simulate the trabecular structure of bone to maximise porous space for bone ingrowth. Plasma-sprayed hydroxyapatite coatings work well on non-porous substrates but do not coat the inner surfaces of open-porous substrates. Chemical deposition is an attractive alternative that produces consistent coats on porous surfaces. Method: Titanium foam cylinders (5mm diameter by 25mm length) were implanted bilaterally in 40 rabbit femurs. Twenty implants were coated with 20 microns of hydroxyapatite (T-HA) by electrochemical deposition while 20 implants had no hydroxyapatite coat (T). Osseointegration was measured at six and 12 weeks by automated computerised histomorphometry of scanning electron microscopy images of sections taken through the implant at two levels: diaphyseal and metaphyseal. Bone ingrowth was quantified in the pores and was also measured up to 1mm beyond the surface of the implant to determine the pattern of bone growth. Results: For the T-HA surface, bone ingrowth increased from 35.0 ±8.5 % at six weeks to 41.5 ± 7.4 % at 12 weeks (p < 0.05). For the T surface, bone growth was 14.1 ± 8.8% at six weeks and 11.4 ± 4.2 % at 12 weeks. At both time points mean bone ingrowth was significantly different between hydroxyapatite-coated and non-hydroxyapatite-coated implants, (p< 0.01). No significant differences were noted between the diaphyseal and metaphyseal bone response. Conclusion: For the T-HA surface, bone ingrowth increased from 35.0 ±8.5 % at six weeks to 41.5 ± 7.4 % at 12 weeks (p < 0.05). For the T surface, bone growth was 14.1 ± 8.8% at six weeks and 11.4 ± 4.2 % at 12 weeks. At both time points mean bone ingrowth was significantly different between hydroxyapatite-coated and non-hydroxyapatite-coated implants, (p< 0.01). No significant differences were noted between the diaphyseal and metaphyseal bone response

Aims. Coatings for endo-osseous implants have been developed based on phospholipids. Such coatings promote the formation of a very thin superficial layer which is highly enriched with calcium phosphates. Aim of this study is a comparison of such coatings with an hydroxyapatite coating. Methods. Two phospholipid-based preparations have been compared with a standard hydroxyapatite coating. Preparation S was based on phosphatidyl-serine; preparation C was based on a mixture of phosphatidyl-serine, phosphatidyl-choline and cholesterol. Titanium cylinders wrapped with titanium foam were the metallic substrate for the coatings; they were implanted in the femural canal of New Zealand White rabbits and retrieved after 4, 8 and 26 weeks. A Back Scattered Electron Microscopy analysis followed. Results. Both phospholipid preparations showed to have no inhibitory action on bone apposition and growth and did not elicit any adverse fibrous reaction. Pictures of bone in-growth into the cavities of the titanium foam were present. A tight apposition between bone and coating was evident only in the comparative group sprayed with hydroxyapatite, but this latter coating was often fragmented and its constituent granules were evident. Conclusion. Phospholipid-based coatings showed no inhibitory action on bone apposition and growth and did not elicit any adverse fibrous reaction

Porous blocks of calcium hydroxyapatite ceramic were evaluated as delivery systems for the sustained release of antibiotics. We tested gentamicin sulphate, cefoperazone sodium, and flomoxef sodium in powder form placed in a cylindrical cavity in calcium hydroxyapatite blocks, using in vitro studies of elution and in vivo studies in rats. Gentamicin sulphate gave a maximum concentration within the first week, which gradually decreased but was still effective at 12 weeks, when 70% of the antibiotic had been released. Even at this stage the antibiotic concentration from a 75 mg dose was five times the minimum inhibitory concentration for staphylococci. In the in vivo studies the release of gentamicin sulphate into the normal bone of rats was at similar rates and levels. The bacteriocidal activity of the drugs was not affected by packing into calcium hydroxyapatite ceramic and the blocks were completely biocompatible on histology. This new system overcomes the disadvantages of other drug delivery systems, avoiding thermal damage to the antibiotics and a second operation for the removal of the carrier. Some mechanical strength is provided by the ceramic and healing may be accelerated by bone ingrowth into its micropores

Introduction. We have investigated middle-term clinical results of total hip arthroplasty (THA) cemented socket with improved technique using hydroxyapatite (HA) granules. IBBC (interfacial bioactive bone cement method, Oonishi) (1) is an excellent technique for augmenting cement-bone fixation in the long term. However, the technique is difficult and there are concerns over some points, such as bleeding control, disturbance of cement intrusion to anchoring holes by granules, difficulty of the uniform granular dispersion to the acetabular bone. To improve the original technique, we have modified IBBC (M-IBBC), and investigated the middle-term clinical results and radiographic changes. Materials and Methods. K-MAX HS-3 THA (Kyocera, Japan), with tapered cemented stem with small collar and all polyethylene cemented socket, was used for THA implants (Fig.1). Basically the third generation cementing technique was used for THA using bone cement. The socket fixation was performed with bone cement (Endurance, DePuy) and HA granules (Ca10(PO4)6(OH)2, Boneceram P; G-2, 0.3–0.6mm in size, Olympus, Japan) (Fig.2). In original IBBC technique, HA granules were dispersed on reamed acetabulum before cementing. In M-IBBC technique, HA granules were attached to bone cement on plastic plate, then inserted to reamed acetabulum and pressurized (Fig.3). 112 hip joints (95 cases) were operated between June 2010 and March 2014, and followed. The average follow-up period was 6.5 years, and average age at operation was 66.5 years. The clinical results were evaluated by Japan Orthopaedic Association Hip Score (JOA score), and X-p findings were evaluated using antero-posterior radiographs. The locations of radiolucent lines were identified according to the zones described by Delee and Charnley for acetabular components, and Zone 1 was divided into two parts, outer Zone 1a and inner Zone 1b. Results and Discussion. Revision was not performed. JOA score improved from 47 to 88. Socket and stem loosening was not observed. X-p findings of sockets demonstrated radiolucent line in Zone 1a/1b/2/3 in 0.9/0/0/0% immediately after the operation, 6.3/1.8/0/0.9% at 2 years postoperatively. After 2 years there was no progressive change, however, improvement of radiolucent line in Zone 1a was observed in two cases after 3 years postoperatively. Accordingly, at 5 years radiolucent line in Zone 1a/1b was observed in 4.4/1.8%. Oonish has reported excellent clinical results of THA with IBBC (1). To easily perform IBBC, we have modified the technique, improving the problems of IBBC. In this study, radiolucent line was observed at the margin of the socket in a small number of cases, and there was no progressive change. In addition, improvement of radiolucent line was observed in M-IBBC in this study, which was not observed in conventional cementing technique. Conclusions. It is demonstrated that M-IBBC provides stable socket cement fixation for THA. The interesting finding in M-IBBC cases was the improvement of radiolucent line, suggesting osteoconductive property of hydroxyapatite granules at the interface after the operations. The promising long-term clinical results of M-IBBC method, were expected. For any figures or tables, please contact the authors directly

We report the histological findings in post-mortem specimens obtained ten days, 17 days and seven weeks after implantation of hydroxyapatite-coated femoral components of hip arthroplasties. There was early deposition of woven bone on the hydroxyapatite ceramic, identical to that deposited on surviving cancellous trabeculae. The space between these deposits became bridged from both sides by new trabeculae, and there was no evidence of an inflammatory reaction or of fibrous tissue formation. The use of an hydroxyapatite coating seems to allow early, sound, secondary fixation of implants

A silver-containing hydroxyapatite (Ag-HA) coating has been developed using thermal spraying technology. We evaluated the osteoconductivity of this coating on titanium (Ti) implants in rat tibiae in relation to bacterial infection in joint replacement. At 12 weeks, the mean affinity indices of bone formation of a Ti, an HA, a 3%Ag-HA and a 50%Ag-HA coating were 97.3%, 84.9%, 81.0% and 40.5%, respectively. The mean affinity indices of bone contact of these four coatings were 18.8%, 83.7%, 77.2% and 40.5%, respectively. The indices of bone formation and bone contact around the implant of the 3%Ag-HA coating were similar to those of the HA coating, and no significant differences were found between them (bone formation, p = 0.99; bone contact, p = 0.957). However, inhibition of bone formation was observed with the 50%Ag-HA coating. These results indicate that the 3%Ag-HA coating has low toxicity and good osteoconductivity, and that the effect of silver toxicity on osteoconductivity depends on the dose

The durable fixation of an uncemented cup is due to two major factors: the primary stability obtained by the design of the cup and the secondary fixation obtained by the features of the surface of the cup. The CSF (cancellous screws fixation) cup is an emispheric press-fit Hydroxyapatite coated cup that has 5 holes for screws. This permit to insert screws not only in the superior part of the acetabulum but also in the inferior and supero-medial. This theoretically guarantee, also in those cases in which a perfect press-fit was non achievable, a good primary fixation. This primary fixation permit the osteo-conductive function of the HA coating in order to gain secondary e more stable fixation. From january 1999 to september 2003 we per-formed130 uncemented THR with the CSF cup and the Furlong stem. In the first 100we always insert three screws. In the next 30 only in case of a non perfect-press-fit (10). The mean age was 65 years (14–80). The follow-up varying from 5 years to 6 months. The study is retrospective. At the last follow-up all implants resulted well integrated.. The formation of new trabecular bone bonding the cup was noted on the X-ray since the third month’s control. There was no complication due to the position of the screws. All patients regained full authonomy. Primary stability is mandatory in order to obtain a good secondary fixation by osteointegration. The possibility to insert additional screws in a triaxial fashion permit to obtain good primary stability. in all the cases. The screws must be inserted carefully under X-ray in order to avoid complications. Hydroxyapatite, guiding the growth of new trabecular bone bonding the cup to the pelvic bone, guarantee a good secondary fixation

Introduction We report the clinical and radiographic outcome of a consecutive series of 138 hydroxyapatite coated total knee replacements with a mean follow up of 11 years (10–13 years). Method and Results These patients were entered into a prospective study. There were 74 females and 32 males. Indications for surgery were osteoarthritis in 131 knees, rheumatoid arthritis in 5 knees and pigmented villo-nodular synovitis in 2 knees. The mean age of the patient was 72.5 years at the time of surgery. All living patients (76 knees) were examined and X rayed. A current Hospital for Special Surgery knee score (mean 83 points) was obtained for comparison with the preoperative profile (mean 55 points).The knee status of deceased patients was known within the year of death. No patient was lost to follow up. Radiological evaluation, assessed according to the method described by the Knee Society, revealed no loosening in surviving patients, and there are no impending revisions. Seven prostheses have been revised, giving a cumulative survival rate of 93 percent at 13 years. Discussion. We believe this to be the longest follow up report available for an hydroxyapatite coated knee replacement, and the first using the Insall Burstein knee. Results can thus be compared with the identical prosthesis using cemented fixation. Further modifications would be likely to improve reliability

The material most widely used in orthopaedics is hydroxyapatite (HA), anyway many differences are still present between synthetic HA and biological HA. The aim of this study was to compare adhesion, proliferation and differentiation of human osteoblast-like cells on hydroxyapatite discs with different porosity and on plastic cultures. Human osteoblast-like cells were isolated from 4 young patients (mean age 24.5 years old), treated with collagenase and maintained in Dulbecco’s modified essential medium-10% fetal calf serum. Cells were plated on hydroxyapatite discs with 3 different porosities (35%, 35–55% e 55%) and on plastic cultures used as control. The proliferation was determined by the MTT colorimetric method, and alkaline phosphatase (ALP) activity was measured by a spettrophotometric method. Type I collagen and osteonectin production were demonstrated with fluorescence microscopy and osteoblast adhesion was studied by scanning electron microscopic (SEM) analysis. Results were analysed by one-way analysis of variance (ANOVA). Osteoblast proliferation on HA was three- to six-fold lower then on plastic. At 28 days, 2141 (± 350) cells/well grew on the most porous disks, with highly significant differences from controls. The ALP production was 2–3 fold lower on HA than on plastic. In the most porous disks, the mean ALP activity was of 2.95 (± 0.07) UI/well after 28 days, higher than in the other two groups. The type-I collagen and the osteonectin fluorescence reaction evidenced a cytoplasmic and a matrix labeling on HA at different porosities. SEM analysis showed osteoblasts with a flattened morphology and only few of them were metabolic active. At 21 and 28 days, proliferation rate and ALP activity on the three HA cultures were significantly different (p< 0.05). A decrease in cell population and increased ALP activity were observed on the most porous material, and high proliferation and poor differentiation rates on the less porous disks

Introduction. The addition of hydroxyapatite in cementless total knee arthroplasty is believed to reduce the time for implant fixation and rehabilitation, reduce the incidence of RLLs and provide long lasting implant stability, through improved osseointegration. We report the results of a prospective, randomised controlled single blinded study comparing the post operative pain, biological fixation and clinical outcomes with the LCS Complete Porocoat and the hydroxyapatite-coated, LCS Complete Duofix mobile-bearing knee systems. Methods. Two hundred and four patients for TKA were prospectively recruited into the study between November 2006 and November 2008. Subjects were randomly assigned to receive the LCS Complete Duofix or LCS Complete Porocoat knee systems. Outcomes including VAS pain scores, American Knee Society scores and Oxford knee scores were performed pre-operatively and at 3 months. X-rays were analysed by an independent reviewer for the presence of radiolucent lines. Results. At no time point from immediately post-operatively to 3 months post-operatively was there a statistically significant difference between groups, in terms of reduction in pain, as measured by the VAS pain score (p=0.9575). American Knee Society and Oxford Knee scores showed similar results between groups. In terms of fixation of the prostheses, radiological analysis revealed a statistical difference between the study groups, Odds Ratio 28.17 (3.670, 216.3), with Duofix having fewer radiolucent lines than Porocoat. 25% of the Porocoat tibias were assessed as not fixated at 3 months whereas only 1% of the Duofix tibias were considered not fixated. There was no significant difference in pain between the fixated and not fixated groups (p=0.293). Conclusions. The addition of hydroxyapatite did not make a significant difference in terms of pain or functional outcomes in the early post-operative period, but did reduce the incidence of radiolucent lines. The presence of radiolucent lines was not associated with increased pain

We studied two groups of femoral hip prostheses: 43 TiAlV ridged press-fit stems, and 26 with similar stems coated with hydroxyapatite on the proximal half. At one year, radiological measurement showed a mean downward migration of 0.99 mm for the TialV prostheses and 0.12 mm for the HA-coated prostheses (p = 0.0002). Hydroxyapatite coating appeared to provide effective bio-active supplementary fixation

Worldwide 500,000 cases of maxillofacial cancer are diagnosed each year. After surgery, the reconstruction of large bone defect is often required. The induced membrane approach (Masquelet, 2000) is one of the strategies, but exhibits limitations in an oncological context (use of autografts with or without autologous cells and Bone Morphogenetic Proteins). The objectives of this work are to develop an injectable osteoinductive and osteoconductive composite matrix composed of doped strontium (Sr) hydroxyapatite (HA) particles dispersed within a polysaccharide scaffold, to evaluate in vitro their ability to stimulate osteoblastic differentiation of human mesenchymal stem cells (hMSC) and to stimulate in vivo bone tissue regeneration. HA particles were synthesized with different ratios of Sr. X-ray diffraction (XRD), Inductively Coupled Plasma (ICP), and particle size analysis (Nanosizer™) were used to characterize these particles. HA and Sr-doped HA were dispersed at different ratios within a pullulan-dextran based matrices (Autissier, 2010), Electronic scanning microscopy Back Scattering Electron microscopy (ESEM-BSE) and ICP were used to characterize the composite scaffolds. In vitro assays were performed using hMSC (cell viability using Live/Dead assay, expression of osteoblastic markers by quantitative Polymerase Chain Reaction). Matrices containing these different particles were implanted subcutaneously in mice and analyzed by Micro-Computed Tomography (micro-CT) and histologically (Masson's trichrome staining) after 2 and 4 weeks of implantation. XRD analysis was compatible with a carbonated hydroxyapatite and patterns of Sr-doped HA are consistent of Sr substitution on HA particles. Morphological evaluation (TEM and Nanosizer™) showed that HA and Sr-doped HA particles form agglomerates (150 nm to 4 µm). Matrices composed with different ratios of HA or Sr-doped-HA, exhibit a homogenous distribution of the particles (ESEM-BSE), whatever the conditions of substitution. In vitro studies revealed that Sr-doped HA particles within the matrix stimulates the expression of osteoblastic markers, compared to non-doped HA matrices. Subcutaneous implantation of the matrices demonstrated the formation of a mineralized tissue. Quantitative analyses show that the mineralization of the implants is dependent of the amount of HA particles dispersed, with an optimal ratio of 5% of particles. Histological analysis revealed osteoid tissue in contact to the matrix. In conclusion, the ability of this injectable composite scaffold to promote ectopically tissue mineralization is promising for bone tissue engineering. Osseous implantation in a femoral bone defect in rats is now in progress. 5% of doped HA particles were implanted within the induced membranes in a context of radiotherapy procedure. Micro-CT analyses are ongoing. This new matrix could represent an alternative to the autografts for the regeneration of large bone defects in an oncological context

Introduction. We aimed to determine the extent of osseous integration of the hydroxyapatite collars of tumour endoprostheses implanted in our unit. Methods. We identified 57 patients who had massive endoprostheses implanted over the last six years and reviewed clinical records and x-rays. There were 20 proximal femoral, 23 distal femoral, 6 proximal tibial, 8 proximal humeral and 1 distal humeral replacements. Patients fell into three groups: 1.Primary bone tumours, 2. Metastatic bone tumours and 3. Non-tumour indications. Results. There were 32 patients in Group 1. Mean age 32(10-71) years. Mean follow up was 22 (12-60) months. Osseous integration of the collars was noted in 19 patients (60%). Eight patients had no bony ongrowth on the collars. Nine patients underwent revision, seven for aseptic loosening and one for infection. There were 23 patients in Group 2. Mean age 72(45-83) years. The primary tumour was lung in four and renal in three. One patient had bilateral surgery. Mean follow up was 6(4-9) months. One prosthesis required revision for aseptic loosening in spite of showing good growth over the collar. True osseous integration of the collar occurred only in one patient. There were two patients in Group 3: one with a distal femoral fracture non union who demonstrated good integration of the collar. The other had a revision for infected total hip replacement with no osseous integration. Discussion. Hydroxyapatite coated collars may help integration of massive endoprostheses, but ongrowth is not always seen. Integration is best after resection of primary bone tumours. Their role in metastatic tumour surgery is questionable

Introduction. Aseptic loosening is the most common mode of failure of massive endoprostheses. Introduction of Hydroxyapatite coated collars have reduced the incidence of aseptic loosening. However bone growth is not always seen on these collars. Objectives. The aims of our study were to determine the extent of osseous integration of Hydroxyapatite coated collars, attempt a grading system for bone growth and to determine the effect of diagnosis, surgical technique and adjuvant therapy on bone growth. Methods. We reviewed the records and radiographs of 58 patients who had a massive endoprosthesis implanted by two surgeons in our unit over the last five years. Revision surgeries were recorded separately. Bone growth was graded 1–4 based on appearance in antero-posterior and lateral radiographs. Results. Three groups were identified. Group 1-Resections for primary bone tumours (33 patients), Group 2-resections for metastatic bone disease (22 patients) and Group 3- Resections for non tumour indications (3 patients). Overall, 60% of patients had grade 1, 12% had grade 2, 19% had grade 3 and 9% had grade 4 osteointegration. Grade 3 or 4 Collar osteointegration was found in 37% of patients in Group 1, 9% in group 2 and 67% in group 3. 5% of patients with grade 1 integration, 100% patients with grade 2 integration and none of the patients with grade 3 or 4 integration underwent revision for aseptic loosening. Appearance or widening of a gap between the resected bone end and the collar indicated loosening and impending revision. Proximal humeral replacements had the lowest rate of osteointegration (12%). Adjuvant therapy did not affect osteointegration. Conclusion. Osteointegration of collars is seen more often after resection of primary bone tumours. The role of collars in metastatic tumour surgery is questionable. Our radiographic grading system of bone growth predicted aseptic loosening

Introduction. Management of open fractures is challenging and requires a multidisciplinary team approach. Gustilo Anderson Type IIIB fractures reportedly have a higher infection rate (up to 52%) and up to 16% amputation rate. This study aims to evaluate outcomes of using Adjuvant Local Antibiotic Hydroxyapatite Bio-Composite in management of Open Gustilo-Anderson IIIB fractures. Materials and Methods. We reviewed a prospective data of 80 patients who presented with Gustilo Anderson Type IIIB Open Fracture to a single ortho-plastic centre. Only patients who were managed with single-stage “Fix and Flap” along with intra-operative Adjuvant Local Antibiotic Bio-Composite were included. Results. Mean follow-up time was 22 months. The mean time from injury until definitive surgery was 7.73 days (1–30 days). Primary union achieved in 88.3% within 32 weeks on average. The delayed union reported in 7.8% of patients, for the bone healing stimulated by injecting the fracture site with Autologous Bone Marrow Aspirate Concentrate. Subsequent follow-up showed signs of successful fracture healing at 60 weeks post-injury. Three patients (3.9%) had non-union. Limb salvage rate was 96.25%, and only 1.25% deep infection rate. Conclusions. Our results highlight that low infection rates, high limb salvage rates and high union rates can be achieved in these complex injuries with a combined OrthoPlastic approach, MDT input, meticulous technique and the use of adjuvant local antibiotic bio-composite. Delay in definitive surgery, gentamicin resistance and smoking were not associated with any increased deep infection or non-union in our series. At 22 months of follow-up, deep infection rate was 1.25%, limbs salvage rate was 96.25%, fracture union rate was 96.1%, and reoperation rate 18.75%

This study reports the results of 38 total hip arthroplasties (THAs) in 33 patients aged <  50 years, using the JRI Furlong hydroxyapatite ceramic (HAC)-coated femoral component. This represents an update of previous reports of the same cohort at ten and 16 years, which were reported in 2004 and 2009, respectively. We describe the survival, radiological and functional outcomes at a mean follow-up of 21 years (17 to 25). Of the surviving 34 THAs, one underwent femoral revision for peri-prosthetic fracture after 21 years, and one patient (one hip) was lost to follow-up. Using aseptic loosening as the end-point, 12 hips (31.5%) needed acetabular revision but none needed femoral revision, demonstrating 100% survival (95% confidence interval 89 to 100). In young patients with high demands, the Furlong HAC–coated femoral component gives excellent long-term results. Cite this article: Bone Joint J 2015;97-B:749–54

We report on 397 consecutive revision total hip replacements in 371 patients with a mean clinical and radiological follow-up of 12.9 years (10 to 17.7). The mean age at surgery was 69 years (37 to 93). A total of 28 patients (8%) underwent further revision, including 16 (4%) femoral components. In all 223 patients (56%, 233 hips) died without further revision and 20 patients (5%, 20 hips) were lost to follow-up. Of the remaining patients, 209 (221 hips) were available for clinical assessment and 194 (205 hips) for radiological review at mean follow-up of 12.9 years (10 to 17.7). The mean Harris Hip Score improved from 58.7 (11 to 92) points to 80.7 (21 to 100) (p <  0.001) and the mean Merle d’Aubigné and Postel hip scores at final follow-up were 4.9 (2 to 6), 4.5 (2 to 6) and 4.3 (2 to 6), respectively for pain, mobility and function. Radiographs showed no lucencies around 186 (90.7%) femoral stems with stable bony ingrowth seen in 199 stems (97%). The survival of the S-ROM femoral stem at 15 years with revision for any reason as the endpoint was 90.5% (95% confidence interval (CI) 85.7 to 93.8) and with revision for aseptic loosening as the endpoint 99.3% (95% CI 97.2 to 99.8). We have shown excellent long-term survivorship and good clinical outcome of a cementless hydroxyapatite proximally-coated modular femoral stem in revision hip surgery. Cite this article: Bone Joint J 2014;96-B:730–6

We have investigated the effectiveness of the transplantation of bone-marrow-derived mononuclear cells (BMMNCs) with interconnected porous calcium hydroxyapatite (IP-CHA) on early bone repair for osteonecrosis of the femoral head. We studied 22 patients (30 hips) who had osteonecrosis with a minimum follow-up of one year after implantation of BMMNCs. The mean age at surgery was 41 years (18 to 64) and the mean period of follow-up was 29 months (19 to 48). In a control group, cell-free IP-CHA was implanted into a further eight patients (9 hips) with osteonecrosis of the femoral head and the outcomes were compared. A reduction in the size of the osteonecrotic lesion was observed subsequent to hypertrophy of the bone in the transition zone in the BMMNC group. In three patients in the treatment group progression to extensive collapse was detected. In the control group subtle bone hypertrophy was observed, but severe collapse of the femoral head occurred in six of eight hips. In this limited study the implantation of BMMNCs and IP-CHA appears to confer benefit in the repair of osteonecrosis and in the prevention of collapse

Purpose: Exposure to polyethylene debris and bearing wear is a common feature of total hip prosthesis inserted with or without cement. Osteolysis depends on the number of particles involved and their size. This continuous series of total hip arthroplasties using a Corail prosthesis with 12 years follow-up was studied to assess the course of osteolysis around the prosthesis and the resistance of hydroxyapatite coated implants to the aggression of wear debris. Material and methods: One hundred fifteen patients underwent total hip arthroplasty in 1989 with a Corail prosthesis implanted by the same operator with a metal backed cup and a polyethylene insert. Mean age at implantation was 65 years. Review radiograms were available for 80 patients (38 women and 42 men). Twenty-seven patients had died, five answered a phone interview and three were lost to follow-up. The follow-up was 12 years and analysis was performed on the population with review data and x-rays. Results: There was no case with a loosened stem and none of the patients underwent revision. Twelve cups were however revised for loosening with granuloma. Polyethylene insert wear was seen in 62% of the cases. There was a relationship between the amount of wear debris and the extent of the gramulomas on the femur. These granulomas were basically observed in zones I and VII. Bone defects were curetted and filled with grafts for the 12 cup revisions. The cup bearing was changed in young patients. Good bone healing was a constant finding on follow-up x-rays. Discussion: Hydroxyapatite coated prostheses exhibit good long-term resistance to wear debris which causes osteolysis since none of the Corail femoral stems were destabilised. The granulomas remain localised in the proximal zone and do not descend along the stem or the cement as seen in cemented prostheses. The intimate contact between the recipient bone and the implant appears to form a barrier against migration of wear debris. It thus appears important to achieve good contact all along the stem and to use a totally hydroxyapatite coated implant. Conclusion: Total hip arthroplasty without cement is spared the problem of polyethylene wear debris, but debris must be limited to prevent osteolysis. This observation questions the long-term appropriateness of metal-backed cups with polyethylene inserts and suggests that low friction arthroplasty or use of a hard bearing couple (Cr-Co-Cr-Co or alumina-alumina) should be preferred

In rabbits and goats, test implants with a porous surface of two layers of Tl-6A;-4V beads were examined at intervals for bond strength with bone. Half of the implants were coated with hydroxyapatite by plasma spray. The bonding strength with bone in the coated specimens was about four times greater than that of the uncoated specimens at two weeks, and twice as strong at six weeks. Twelve weeks after implantation, the strengths were similar. The hydroxyapatite coating of the beads provided earlier and stronger fixation

Meniscus has many important functions in the knee joint such as load bearing, shock absorption, joint stability, joint lubrication and proprioception. In the recent years, meniscus injuries have been the focus of orthopaedic surgeons and musculoskeletal tissue engineering applications because of its avascular nature. In this study, we aimed to compare the regeneration capacities of two composite scaffolds in a New Zealand Rabbit meniscal defect model. The first scaffold consists Poly-Lactic Acid (PLA) + chitosan + loofah and the second PLA + Hydroxyapatite (HAp) + loofah. In order to produce these scaffolds; 4% chitosan, 4% PLA and 4% HAp solutions were seperately prepared. The loofah pieces were saturated with these solutions and vacuum-dried for 14 days and sterilized with ethylene oxide. There were several characterizations performed such as Fourier Transform Infrared Spectroscopy (FTIR) for the investigation of chemical structure, Scanning Electron Microscopy (SEM) for morphological analysis, thermogravimetric differential thermal analysis (TGA/DTA) for thermal properties, mechanical compression and swelling ratio analysis. Moreover, in order to investigate biocompatibility of the scaffolds, WST-1 colorimetric assay at days 3, 7, 10, 14 and 21 was conducted. After these biocompatibility analysis, a 1.5-mm cylindrical defect was created in the avascular portion of the anterior horn of the medial meniscus in 14 New Zealand rabbits (2.5–3 kg weight) which were randomly grouped in two. The scaffolds were implanted at the defect site with the help of a freshly prepared fibrin glue. 8 weeks after the operation, the rabbits were sacrificed and their tissues were kept for further mechanical, radiological and histological analysis. In conclusion, we succeeded to produce a new meniscus scaffold. The proliferation ability of PLA + chitosan + loofah scaffold is higher than PLA + HAp + loofah scaffold. However, there was no statistically significant difference among them

Statement of purpose. Cement fixation of total knee replacement (TKR) is commonly cited as being the gold standard, with better long-term survival rates when compared to uncemented fixation so the authors set out to analyse the longterm survivorship without aseptic loosening in a series of 471 uncemented TKR. Methods. A consecutive single surgeon series of patients undergoing routine follow up after a hydroxyapatite coated, uncemented and cruciate retaining TKR performed from 1992 to 1995 were analysed. All patients were invited for clinical review and radiological assessment. Revision of the TKR for aseptic loosening was the primary outcome. Secondary outcomes included Knee Society Score (0–200), range of movement, secondary surgical interventions and the presence of polyethylene wear or osteolysis on plain radiography. Results. 471 TKRs were performed in 356 patients (115 bilateral). 432 TKRs were accounted for through follow up. 39 TKRs in 31 pts were lost to follow-up representing 8% who had a mean KSS of 176 at 10 yr f/u. Mean f/u time period was 16.4 yrs (range 15.1–18.5 yrs). Average age at f/u was 81 yrs. 11 TKR had been revised for aseptic loosening. 19 TKRs in 19 patients had had revision of femoral/tibial components for any reason. A further 7 TKRs had undergone polyethylene insert exchange leaving an overall revision rate of 9% or 91% survival without revision. Survivorship without aseptic loosening was 96% (95%CI of 91.9–98.1%) at up to 18 years. A competing risks analysis was undertaken in order to avoid overestimation of survivorship adjusted for the competing risk of death within the study group. This analysis estimated a cumulative risk of revision for aseptic loosening at 18 years of 4.5%. Mean KSS was 176 (SD 21.5). Mean range of movement was 113 degrees of flexion. Conclusion. Uncemented hydroxyapatite coated total knee replacement can achieve favourable long-term survivorship at least as good as that of cemented designs

Aims

The aim of this study was to evaluate the survival of a collarless, straight, hydroxyapatite-coated femoral stem in total hip arthroplasty (THA) at a minimum follow-up of 20 years.

Purpose. The purpose of this study is to compare using a novel cementing technique with hydroxyapatite granules at bone-cement interface with using the 3. rd. cementing technique on the acetabular component. Patients and Methods. Between 2005 and 2007, we performed 54 primary cemented THAs using the 3. rd. generation cementing technique with hydroxyapatite granules at bone-cement interface (Group A: 21 hips) or without them (Group B: 33 hips) in 49 patients with dysplastic hip (6 males, 43 female; mean age at operation, 67 years; age range, 48–84 years). Mean follow up was 5.3 years (range, 2.3–7.1 years), with none of the patients lost to follow up. According to Crowe's classification, subluxation was Group I in 31 hips, group II in 11 hips, group III in 8 hips, and group IV in 4 hips. We used Exeter flanged cup, Exeter stem with a 22-mm diameter metal head (Stryker, Benoist Girard, France) and Simplex-P bone cement (Stryker, Limerick, Ireland) in all hips. A posterolateral approach was performed for all patients. Bone graft was performed 25 hips (block bone graft: 11 hips; impaction bone grafting with a metal mesh: 13 hips) from autogeneic femoral head. Our 3. rd. cementing technique is to make multiple 6-mm anchor holes, to clean the the host acetabular bed with pulse lavage, to dry it with hydrogen peroxide and to use Exeter balloon pressurizer and Exeter flanged cup. Results. The outcomes showed no aseptic loosening and radiological loosening at final follow up. Radiolucent line around the acetabular component was present 14% in Group A and 42% in Group B at 4 years after operation. Kaplan-Meier survivorship analysis of appearance of a radioluent line around the acetabuler component as the end point was 85.7% on group A was significant higher than 57.6% on group B at 4 years. Conclusion. Radiolucent line around cemented acetabular component in total hip arthroplasty using the 3. rd. cementing technique with hydroxyapatite granules at bone-cement interface was significant higher survivorship than them of the 3. rd. cementing technique at 4 years after operation. We suggest that improved novel cementing technique will lead to greater long-term success outcomes of the acetabular component

Current research efforts aim at enhancing osseointegration of cementless implants to improve early bone fixation. Purpose: The aim of the present study was to investigate whether bone morphogenic protein (BMP) 2 had a positive effect on the osseointegration of hydroxyapatite coated implants. Method: Hydroxyapatite (HA) implants were coated with BMP-2 and hyaluronic acid (HY) as the carrier or with HY alone. Uncoated HA-implants served as controls. The osseointegration of the implants was evaluated either by light microscopy or by pullout tests after 1, 2 and 4 weeks of unloaded implantation in the cancellous bone of 18 sheep. Results: The BMP-2 coating significantly increased bone growth into the perforations of HA-implants. The proportion of bone-ingrowth at 4 weeks was 32% for the BMP-implants compared to 12% for HA implants. However, BMP-2 did not enhance the percentage of bone implant contact and interface shear strength values. Conclusion: This study indicates that BMP-2 may help to increase bone growth across gaps of cementless implants in the early stages of bone healing improving fixation and decreasing the risk of loosening

Current research efforts aim at enhancing osseointegration of cementless implants to improve early bone fixation. The aim of the present study was to investigate whether bone morphogenic protein (BMP) 2 had a positive effect on the osseointegration of hydroxyapatite coated implants. Hydroxyapatite (HA) implants were coated with BMP-2 and hyaluronic acid (HY) as the carrier or with HY alone. Uncoated HA-implants served as controls. The osseointegration of the implants was evaluated either by light microscopy and pullout tests after 1, 2 and 4 weeks of unloaded implantation in the cancellous bone of 18 sheep. The BMP-2 coating significantly increased bone growth into the perforations of HA-implants. The proportion of bone-ingrowth at 4 weeks was 32% for the BMP-implants compared to 12% for HA implants. However, BMP-2 did not enhance the percentage of bone implant contact and interface shear strength values. Conclusion: This study indicates that BMP-2 may help to increase bone growth across gaps of cementless implants in the early stages of bone healing improving fixation and decreasing the risk of loosening

Aims. Hydroxyapatite coatings for uncemented fixation in total knee arthroplasty can theoretically provide a long-lasting biological interface with the host bone. The objective of this study was to test this hypothesis with propriety hydroxyapatite, peri-apatite, coated tibial components using component migration measured with radiostereometric analysis over two years as an indicator of long-term fixation. Patients and Methods. A total of 29 patients at two centres received uncemented PA-coated tibial components and were followed for two years with radiostereometric analysis exams to quantify the migration of the component. Results. While there was significant variation in individual migration patterns, the overall migration of the tibial component in the study group demonstrated a pattern of initial migration followed by stabilisation after one year, with mean maximum total point motion (MTPM) of 0.02 mm (standard deviation (. sd. ) 0.20) between one and two years post-operatively. The direction of greatest motion was subsidence, which stabilised at three months post-operatively (mean translation of 0.21 mm, . sd. 0.40). Conclusion. The tibial component migration pattern of stabilisation in the second post-operative year is indicative of successful long-term fixation for this PA-coated tibial component. Cite this article: Bone Joint J 2017;99-B:1596–1602

The outcome at ten years of 100 Freeman hip stems (Finsbury Orthopaedics, Leatherhead, United Kingdom) retaining the neck with a proximal hydroxyapatite coating in a series of 52 men (six bilateral) and 40 women (two bilateral), has been described previously. None required revision for aseptic loosening. We have extended the follow-up to 20 years with a minimum of 17 years. The mean age of the patients at total hip replacement was 58.9 years (19 to 84). Six patients were lost to follow-up, but were included up to their last clinical review. A total of 22 patients (22 hips) had died, all from causes unrelated to their surgery. There have been 43 re-operations for failure of the acetabular component. However, in 38 of these the stem was not revised since it remained stable and there was no associated osteolysis. Two of the revisions were for damage to the trunnion after fracture of a modular ceramic head, and in another two, removal of the femoral component was because of the preference of the surgeon. In all cases the femoral component was well fixed, but could be extracted at the time of acetabular revision. In one case both components were revised for deep infection. There has been one case of aseptic loosening of the stem which occurred at 14 years. This stem had migrated distally by 7.6 mm in ten years and 8.4 mm at the time of revision at which stage it was found to be rotationally loose. With hindsight this component had been undersized at implantation. The survivorship for the stem at 17 years with aseptic loosening as the endpoint was 98.6% (95% confidence interval 95.9 to 100) when 62 hips were at risk. All remaining stems had a satisfactory clinical and radiological outcome. The Freeman proximally hydroxyapatite-coated femoral component is therefore a dependable implant and its continued use can be recommended

Since 1986 the JRI Furlong hydroxyapatite coated femoral stem has been in use at our institution. We present the results of the first 100 hips performed on 86 patients by or under the direct supervision of one surgeon (JANS). The Furlong stem was used in conjunction with a ceramic head and CCI cemented UHDP cup. AT the time of surgery the mean age of the patients was 69 (range 45–94 years). One patient has undergone excision arthroplasty for suspected infection at which time the femoral component was found to be well bonded. At latest review, all patients were accounted for. 48 patients had died with no death directly related to surgery and no revisions or planned revision of the femoral component at the time of death. Of the 38 surviving patients (44 hips), the mean Merle d’Aubigné & Postel score was 5.8 for pain, 5.7 for movement and 4.9 for function at 13 to 16.5 years follow up (mean 14.0). No femoral component showed radiological evidence of loosening. Five acetabular components have been revised for aseptic loosening with the femoral component found to be well bonded at the time of revision and therefore left in situ. In this series of hydroxyapatite coated femoral stems the overall revision rate is 1% with no cases of aseptic loosening. This hydroxyapatite coated prosthesis, at long term follow up has superior survival figures to other types of femoral components

For successful long-term result of non-cemented total hip arthroplasty (THA), direct biological bond between bone and implant through bony ingrowth into the implant is essential. To facilitate strong bond between bone and implant, hydroxyapatite (HA) or hydroxyapatite and tricalcium phosphate (HA-TCP) coated implants have been developed. Early clinical results of HA coated implants were reported very satisfactorily. However, the long-term effects of HA or HA-TCP coating on implants were still controversial. We evaluated the effect of hydroxyapatite and tricalcium phosphate (HA-TCP) coating on fibermetal coated femoral stem. 37 cases using fibermetal coated femoral stem with additional HA-TCP coating and 38 cases using fibermetal coated femoral stem without additional HA-TCP coating were included with average follow-up for 127 months. The mean Harris hip score at final follow-up 91.2 in HA-TCP group and 90.5 in porous group. Engh’s score at final follow-up was 19.1 in HA-TCP group and 18.7 in porous group. Six acetabular components (8.0%, 3 cases in each group) were revised for excessive PE liner wear and liner dissociation from locking mechanism. One femoral stem without HA-TCP coating was considered as a loosening and failure. None of the remaining femoral components (98.7%) showed any signs of aseptic loosening. No significant differences between two groups were found in all parameters. A cement-less porous coated femoral stem provided good clinical function and survival in the medium term regardless of additional HA-TCP coating

Aim. To evaluate the clinical outcome of a new absorbable, gentamycin loaded calcium sulfate/hydroxyapatite biocomposite (CERAMENT. ™. /G) as cavity filler after debridement and removal of infected metalwork in chronic osteomyelitis. Methods. We report the retrospective study of prospectively collected data from 36 patients with chronic osteomyelitis from implant infection. Treatment included a single stage protocol with removal of the metalwork, debridement augmented with application of CERAMENT. ™. /G, stabilization, culture-specific antibiotics and primary skin closure or flap. The biocomposite was used for dead space filling after resection of Cierny-Mader (C-M) stage III and IV chronic osteomyelitis. Data were collected on patient age, comorbidities, operation details, microbiology, postoperative complications and type of fixation or plastic surgery. Primary measure of outcome was recurrence rate. Results. According to the C-M classification 22 patients (63%) were defined as Type III and 13 (37%) as Type IV. A total of 26 (72%) patients were Class B hosts. In 9 cases (25%), there was an infected non-union and 1 patient had septic arthritis. Mean age was 52 years (range 22 to 81). Patients were followed for a mean of 20 months (range 6 to 36). Infection was eradicated in 32 patients. There were three (8.3%) recurrences (two cases of osteomyelitis and one of soft tissue/flap infection). Two of them were successfully managed with repeat surgery (one Class B and one Class A host) and one (Class B host) with suppressive antibiotic therapy as per patient's choice. In one infected nonunion the infection was eradicated but the nonunion persisted. Thirteen patients (36.6%) had a local or free fascio-cutaneus flap. Staphylococci (50%) and Enterococci (15%) were the most common microorganisms. Pseudomonas aeruginosa was more common in polymicrobial infection usually with Staphylococcus aureus. Conclusions. A multidisciplicary approach including augmented debridement with CERAMENT. ™. /G is effective for treatment of chronic osteomyelitis with infected metalwork

Cemented stem fixation is a proven technique in total hip arthroplasty (THA), however, aseptic loosening is a noted complication. Cementless fixation is also popular in THA, however thigh pain and osteolysis are known problems with short-term and long-term follow- up, respectively. In order to improve the initial development and durability of the osseointegration of porous coated cementless implants, hydroxyapatite (HA) has been claimed to provide a biological adjuvant for femoral stem fixation in THA. There is no prospective, randomised long-term study comparing clinical radiographic findings between proximally HA-coated and non-HA coated surfaces of an identical stem design. We investigated 177 patients (199 hips) who received either HA-coated or non-HA coated stems. Clinical information from 163 patients (181 hips), including walking ability, thigh pain, sports activity, and overall patient satisfaction was collected. Evidence of radiolucencies, stem migration, and canal fill was measured on AP and lateral radiographs. In addition, tension trabeculae on the lateral aspect of the proximal stem and stress-induced remodelling of cancellous bone against porous surface (SIRCAP) were noted as signs of bone ingrowth. Both groups of patients performed well on the basis of HSS scores, walking ability, sports activity, and overall patient satisfaction. However the non-HA group demonstrated a significant increase (p< 0.05) in activity- related thigh pain. There were no significant radiographic differences between patient cohorts with all stems demonstrating bone ingrowth. In our prospective, randomised study, we conclude that the use of HAcoated stems results in increased clinical satisfaction to the THA patient

Impacted morsellised allografts have been used successfully to address the problem of poor bone stock in revision surgery. However, there are concerns about the transmission of pathogens, the high cost and the shortage of supply of donor bone. Bone-graft extenders, such as tricalcium phosphate (TCP) and hydroxyapatite (HA), have been developed to minimise the use of donor bone. In a human cadaver model we have evaluated the surgical and mechanical feasibility of a TCP/HA bone-graft extender during impaction grafting revision surgery. A TCP/HA allograft mix increased the risk of producing a fissure in the femur during the impaction procedure, but provided a higher initial mechanical stability when compared with bone graft alone. The implications of the use of this type of graft extender in impaction grafting revision surgery are discussed

Cemented Total Hip Arthroplasty gives good results for 10 or more years, but is too often complicated by a combination of mechanical loosening, wear debris and osteolysis. Patients require an implant which will last the rest of their life. Cemented hips may not survive and a better alternative is needed. Furlong hydroxyapatite ceramic coated (HAC) implants have been used for more than 19 years and to date there are 2248 primary hip arthroplasties. Fixation of the implants with HA ceramic is entirely satisfactory; histological studies from post-mortem specimens have confirmed that there is good cancellous bone fixation to the HA. The hydroxyapatite behaves like bone and is replaced by creeping substitution. This results in a Perfect Fit with no intervening fibrous tissue. Fixation is therefore maintained. Aseptic loosening is rare; eleven components. Polythene wear is a problem. Those patients with ceramic/polythene couples who have now reached about 15 years since surgery are showing wear of the liner evidenced by eccentricity of the ceramic head in the liner. Three of these have completely destroyed the liner and the titanium shell. Ceramic/ceramic bearings do not seem to wear, although there have been occasional fractures of alumina. For the last two years Biolox Delta, a stronger compound ceramic material, has been available from Ceramtec. There are no reports of any fractures. Patients who have a life expectancy of more than 10 or 15 years should be fitted with an HA coated implant with ceramic bearing surfaces. This may provide the answer for the long-lasting hip prosthesis

Introduction. Core decompression is used in precollapse lesions to forestall disease progression in avascular necrosis (AVN) of femoral head (FH). The author reports a new technique using reverse bone graft technique to effectuate core decompression. Aim. To prevent precollapse in Ficat Type 1&2 and revascularization using synthetic bone graft material. Methods. A 18 year female police trainee with Magnetic Resonance Imaging (MRI) confirming AVN Stage 2 Ficat, clinically painful hip not evident in x-rays consented to undergo this new technique. Reverse bone graft technique with a Coring reamer – Patent 5423823. A minimally invasive technique with lateral 2 cm incision introducing 8.5 mm core reamer to remove a core of bone up to the subchondral bone. The subchondral cyst decompressed and curetted under video recorded Image Intensifier (II). Demarcated avascular bone segment excised and bone graft reversed and inserted with cortical bone acting as a support to prevent collapse and the distal segment augmented using 5 grams of osteoconductive granular synthetic bone graft material based on calcium phosphate hydroxyapatite (HA 2500–5000 μm). Avascular segment histopathologically confirmed AVN. The metaphyseal entry was extrapoliated at the lateral cortex using the combined necrotic angle described by Kerboul in the anteroposterior and lateral views under II. Protected weight bearing for 2 months to prevent stress riser. Biomaterials. HA granules named as GranuMas™ developed under Intensified Research in Priority Areas (IRPA) Research Project (No. 03-01-03-0000-PR0026/05) and invented by the Advance Materials Research Centre (AMREC) and manufactured by GranuLab –Patent P1 20040748 fulfilling the criteria for American Society for Testing and Materials (ASTM) F1185-88(1993) Standards which is ‘Standard Specification for Composition of Ceramic Hydroxyapatite for Surgical Implants’. Derived from Malaysian limestone, ranging from 200–5000 μm gamma sterilized. Results. After 6 months, there was no collapse of subchondral bone and the FH showed revascularization along bone grafted site with viable graft and increased radiotracer activity using 99-Tc MDP Bone Planar Scintigraphy. Clinical analysis follow up at 2 years was descriptive rather than statistical with a x-ray evident incorporated graft and with pain free full range of movement. Discussion. Reduction in intraosseous pressure is achieved by using large bore 8.5 mm coupled with HA granules promoting revascularization. The core tract entering through the metaphyseal region reduces risk of subtrochanteric fracture a potential complication of vascularized fibular grafts and with less morbidity with other treatment methods for osteonecrosis of the femoral head. The concept can be extended in introducing stem cell and biologic material to treat AVN. Conclusion. This technique is minimally invasive and effective in young patients with early stage of FH AVN and has shown revascularization along the bone grafted site

Summary Statement. Parathytorid hormone-related protein (107–111) loaded onto biopolymer-coated nanocrystalline hydroxyapatite (HA. Glu. ) improves the bone repair in a cavitary defect in rat tibiae. Introduction. Biopolymer-coated nanocrystalline hydroxyapatite (HA. Glu. ) made as macroporous foams are promising candidates as scaffolds for bone tissue engineering applications. They exhibit optimal features, promoting internalization, proliferation and differentiation of osteoprogenitors, with an adequate cell colonization over the entire scaffold surface. Parathyroid hormone-related protein (PTHrP) is an important modulator of bone formation. Its 107–111 epitope (osteostatin) exhibits osteogenic properties at least in part by directly acting on osteoblasts. The main aim of this study was to evaluate whether osteostatin loading into HA. Glu. scaffolds might improve their bone regeneration capacity. Materials and Methods. HA. Glu. scaffolds were prepared as previously described (Sánchez-Salcedo S et al. J. Mater. Chem. 2010; 20:6956-61). Osteostatin was adsorbed onto HA. Glu. material by dipping into a solution containing this peptide at 100 nM (in phosphate-buffered saline, pH 7.4), following a standard protocol. We performed a cavitary defect (2 mm in diameter and 3 mm in depth) in both distal tibial metaphysis using a drill under general anesthesia in male Wistar rats (n=8) of 6 months of age. Unloaded HA. Glu. material (7 mg) was implanted into left tibial defects, whereas rigth tibial defects received the osteostatin-loaded material. Animals were sacrificed after 4 weeks for histological, μ-computerised tomography and gene expression analysis of the callus. Our protocol was approved by the Institutional Animal Care and Use Committee at the IIS-FJD. Mouse osteoblastic MC3T3-E1 cells were grown in differentiation medium (α-MEM with 10% fetal bovine serum, 50 µg/ml ascorbic acid, and 10 mM β-glycerolphosphate), in the presence or absence of HA. Glu. material with or without osteostatin. Cell viability (assessed by trypan blue staining), alkaline phosphatase (ALP) activity and mineralization (alizarin red) were analyzed at different culture times. Results. The mean uptake of osteostatin by HA. Glu. scaffolds was about 60 % (representing 0.7 μg/implanted scaffold) after 24 h of loading, and they released a mean of 80 % of loaded peptide to the surrounding medium within 1–24 h. At 4 weeks, this osteostatin-containing HA. Glu. material significantly increased the bone volumen fraction and trabecular thickness of regenerating bone in the tibial methaphysis, compared to those observed with unloaded HAGlu scaffolds. In addition, osteostatin-coated HA. Glu. scaffolds increased (2-fold) the gene expression of osteocalcin and vascular cell adhesion molecule 1, but decreased (2-fold) that of the Wnt inhibitors, SOST and Dickkopf homolog 1 (DKK-1) in the fracture callus. In MC3T3-E1 cell cultures, osteostatin-loaded HA. Glu. material increased cell viability and ALP activity (each by 30%), and matrix mineralization (by 50%) at days 4 and 10, respectively. Conclusions. These results indicate that osteostatin loading improves the bone regeneration capacity of HA. Glu. scaffolds. Our findings suggest that these scaffolds might be promising implants in orthopaedic applications. This work has been supported by a grant from Comunidad Autónoma de Madrid (S-2009/MAT/1472)

Introduction: Modular metaphyseal-diaphyseal femoral stems are infrequent in primary total hip arthroplasty. We analyse the results of a proximally hydroxyapatite coated anatomic two-piece modular femoral stem over a minimum five years follow-up. Material and Methods. 94 ESOP (Fournitures Hospitalieres, France) stems are analysed. The mean follow–up was 70.45 + 8.6 months. Patients’ mean age was 65.8 + 9.6 years. Proximal osteopenia and radiographic stem fixation are assessed according to Engh et al. Results: There were 2 aseptic femoral stem loosenings. There were no cases with thigh pain. Three stems presented subsidence. Mean femoral canal filling was 89% and was related to stem subsidence (p< 0.05). Stable bone fixation was obtained in 83 hips and was related to fluted femora (p< 0.0001). The cumulative probability of not having radiographic loosening was 97.8% (94.8% to 100%). The cumulative probability of not having proximal femoral osteolysis was 86.0% (78.9% to 93.1%), cortical widening 88.1% (81.5% to 94.7%), and proximal osteopenia 94.5% (89.8% to 99.2%). Conclusions: A cementless two-piece modular hydroxyapatite coated femoral stem provides good clinical results with an absence of pain and excellent radiographic results when there is good adaptation between the metaphyseal part of the stem and the femoral anatomy. This design is an option in femora with good bone quality and especially in tunnel-shaped cases. Femoral osteopenia and cortical widening were infrequent in this series. The modular metaphyseal-diaphyseal junction is not an in vivo problem, contrary to previous reports. A longer follow-up is needed to assess the results of this design

We used hydroxyapatite blocks to keep open Salter innominate osteotomies in 19 children (21 hips), avoiding the need for an autograft taken from the anterior superior iliac spine. Our results were satisfactory, with less deformation of the iliac bone, and a reduction of both blood loss and operating time

Introduction: Enchondromas are benign cartilaginous tumors, which are most often localized, in the small bones of the hand. Treatment methods fall into a broad spectrum ranging from conservative, medical therapies, to a variety of surgical procedures, which may or may not employ the use of local adjuvant treatment or bone grafting. Material & Method: We present thirty four patients with hand enchondromas treated surgically in our department during the last eleven years. Their medical records and radiographs were reviewed retrospectively and the patients were contacted and interviewed by telephone. Results: The patients were treated operatively with an intralesional approach, with meticulous curettage of the bone lesion, use of phenol 5% and grafting using coralline hydroxyapatite. X-rays taken over the first postoperative year revealed adequate bone synthesis at the site of enchondroma excavation, and there was no evidence of recurrence, fracture, infection or other complication related to the procedure. Conclusion: We conclude that the combination of curettage of the lesion with the use of phenol as local adjuvant and grafting using coralline hydroxyapatite during the surgical treatment of enchondromas, is a safe technique to reduce or prevent recurrence and allow adequate and uncomplicated local new bone formation

An experimental study was performed in order to investigate methods of preparation and mechanical properties of a potential bone graft substitute. This new composite material consists of porous hydoxyapatite coated with oxidised cellulose. Porous hydoxyapatite has excellent osteoconductive properties and promising strength characteristics. Drawbacks include its lack of osteoinductive properties and its brittle nature. Oxidised cellulose can be functionalised to provide binding sites for proteins, drugs and cells, which would allow for increased osteoinductive activity. It has good tensile strength. By creating a composite of these two substances, it was proposed that a graft substitute could be created. Hydroxyapatite samples were formed by processing and sintering bovine cancellous bone. A method was devised by which cellulose was brought into solution and infiltrated into hydoxyapatite samples. The cellulose was then regenerated (cured) and oxidised. Infrared spectrometry confirmed the desired chemical reactions took place and that oxidised cellulose was formed. Scanning electron microscopy confirmed that the three-dimensional structure of the hydroxyapatite was satisfactorily coated. Crush testing showed that infiltrated samples were less brittle and more likely to hold their shape than control samples. Further development and testing is required to assess this composite material for its biological activity and potential as a bone graft substitute

Introduction: After more than 10 years of clinical experience, hydroxyapatite (HA) coated orthopaedic implants are now an established, viable alternative to porous coatings for achieving good implant fixation. However, developments are continuing to improve the nature and adhesion of the HA coating. Aim: To investigate the biological attachment characteristics of titanium and highly crystalline HA implant coatings in the metaphysis of an animal model. Method: Titanium alloy implants with a coating of commercially pure titanium (Ti) or highly crystalline HA were evaluated by light microscopy and pullout tests after one, two and four weeks of unloaded implantation in the tibial and femoral metaphyses of 18 sheep. Results: The interface shear strength pullout increased from approximately 29N/cm2 at one week to approximately 326N/cm. 2. at two weeks. At four weeks the pull-out strength for Ti and HA coated implants was 1,004.87 ± 189.82N/cm2 and 1,043.26 ± 260.61N/cm2 respectively. The pullout strength increased significantly over time up to four weeks, but the difference between the coatings was not statistically significant at any time interval. Histomorphometric analysis showed an increase of bone-implant contact between one and two weeks from 0 to 15% for Ti and 0 to 20% for HA coated implants. At four weeks Ti and HA implants showed 44% and 60% bone-implant contact respectively. There was a significant increase in bone-implant contact over time for both coatings. HA implants had significantly higher bone-implant contact at two and four weeks. Light microscopy revealed that bone grew into HA coated surfaces in the form of feet, spreading over the surface. Whereas for Ti the newly formed bone looked like a bridge linking the original bone with the implant surface. Conclusion: The different growth patterns of bone into Ti and HA surfaces resulted in different bone-implant contact areas. Highly crystalline hydroxyapatite coatings enhanced the osseointegration in the early stages of bone healing. However there was a discrepancy between the mechanical and histological results. This may suggest that the mechanical failure does not occur at the implant-bone interface

We report the radiological and clinical outcome of a press-fit (SLF) acetabular component at two to three years in two groups of patients having primary total hip replacement. In 69 the implant was coated with hydroxyapatite (HA) and in 40 it was uncoated. The stability of the cup was assessed by measurement of proximal migration and change in the angle of inclination. The clinical results in the two groups did not differ significantly, and the mean proximal linear wear was similar in both. Fewer radiolucent lines (RLLs) were seen on the radiographs of cups coated with HA. The mean proximal migration was studied by calculating regression lines for each patient using migration measurements: for the SLF+HA group the mean slope was 0.06 mm/year and for the SLF–HA group 0.20 mm/year (p = 0.22). The change in the angle of inclination during follow-up was also consistently smaller in HA–coated cups. Using regression methods the SLF+HA group had a mean slope of 0.08°/year and the SLF-HA group 0.44°/year (p = 0.023). Partial HA coating appeared to have no effect on the clinical outcome or on the rate of wear of polyethylene, but there was a trend towards a reduced rate of proximal migration, and a significant reduction in rotational migration and the number of radiolucent lines. This suggests that HA coating enhances the stability of this acetabular component

The use of mesenchymal stem cells (MSCs) for cartilage and bone tissue engineering needs to be supported by scaffolds that may release stimuli for modulate cell activity. The objective of this study was to asses if MSC undergo differentiation when cultured upon a membrane of nanofibers of poly-L-lactic acid loaded with hydroxyapatite nanoparticles (PLLA/HAp). The PLLA/HAp nanocomposite was prepared by electrospinning. Membranes microstructure was evaluated by SEM. MSCs were seeded on PLLA/HAp membranes by standard static seeding and cultured either in basal medium or Chondrogenic Differentiation Medium. Cell attachment and engraftment was assessed 3 days after seeding and MSC differentiation was evaluated by immunostaining for CD29, SOX-9 and Aggrecan under a confocal microscope after 14 days. PLLA/HAp membrane obtained was composed by fibers (average diameter of 7μm) with nano-dispersed hydroxyapatite aggregates (average diameter of 0.3μm). 3 days after seeding, MSCs were well adhered on the PLLA/HAp fibers with a spindled shape. After 14 days of culture all MSCs were positive for SOX-9 in both basal and chondrogenic media groups. Aggrecan was present around the cells. MSCs were either CD29 positive or negative. We demonstrated that PLLA/HAp nanocomposites are able to induce differentiation of MSCs in chondrocyte-like cells. Since HAp has osteoinductive properties, the chondrogenic phenotype acquired by the MSCs may be either stable or an intermediate stage toward enchondral ossification. The presence of CD29 and SOX-9 double positive cells indicate intermediate differentiation phases. This nanocomposite could be a susceptible scaffold for bone or cartilage tissue engineering using undifferentiated MSCs

The proximally hydroxyapatite coated neck retaining Freeman hip stem (Finsbury Orthopaedics, Leather-head, United Kingdom.) was first implanted in 1989. The outcome of the first 100 stems, in 52 men (6 bilateral) and 40 women (2 bilateral) has been reported to ten years, we have extended the follow-up of this series to 17 years. The mean age was 58.9 years (19 to 84). The diagnosis was osteoarthritis for 70 hips, rheumatoid arthritis for seven hips, post-traumatic arthritis for 14 hips and either avascular necrosis, septic arthritis or developmental hip disorder in nine hips. The total hip replacements implanted during the period of study (January 1989 to March 1992) were all secured without cement for either component. The acetabular components comprised press-fitted screw-in Rotalok implants (Corin Medical, Cirencester, United Kingdom) or SLF components (Finsbury). All operations were performed using an anterolateral approach with retention of the femoral neck. Three patients have been lost to follow-up, but are included up to their last clinical follow-up. There have been 40 re-operations for revision of the acetabular component due to aseptic loosening. However, in all but four of these cases the stem was not revised. In two of these the stem revisions were for damage to the trunion following fracture of the modular ceramic head producing fretting against the ceramic debris and acetabular component. In the other two, revision was due to surgeon preference and in both cases well fixed femoral components were extracted at the time of acetabular revision. Osteointegration of these two stems was evidenced by the adherent bone at the time of removal. There has been only one case of aseptic loosening occurring at 14 years. This was found to be rotationally loose at revision and in hindsight was undersized having migrated distally 7.6mm in the first year before stabilising. The survivorship for the stem at 17 years is 98.5% (95% CI; 94.6% to 100%) with 52 patients at risk, all of whom have satisfactory clinical and radiological outcomes. The Freeman uncemented neck retaining proximally hydroxyapatite coated stem has excellent survival results to 17 years

Aims: To evaluate clinical and radiographicl results of hydroxyapatite versus porous coated stems in total hip arthroplasty. Methods: A consecutive randomized series of 447 cementless Titanium prostheses were prospectically studied. The stems (Synergy-Smith& Nephew) were different for the proximal 1/3 hydroxyapatite (HA=268) or titanium porous coating (PC=179) Same cup and ball head were used. Clinical (HHS/Womac) and radiological assessments (Enghñs criteria) were obtained before and after surgery (mean F-U=27,05 months). Results: The clinical outcomes showed a signiþcant improvement in both groups. Bone ingrowth was present in 100% (HA) and 96% (PC) and stable þbrous ingrowth in 4% (PC). Cortical hypertrophy and heterotopic ossiþcation (Brooker 1) were prevalent in HA without limitation of ROM or pain. Stress shielding was equivalent. Nor osteolysis neither subsidence were identiþed. Fractures occurred in 8 cases (HA=6/PC=2) and dislocation in 3 cases. Conclusions: In this study the two types of stems showed good comparable clinical results. The complication were not related to the coating. HA coated prosthesis showed faster osseointegration, and enhanced bone ingrowth. The earlier bone-stable integration obtained in the HA group may be predictive of a lesser degree of osteolysis in the future

Background: Heel valgus and flattening of arch are common in rheumatoid arthritis (RA). The progression of hindfoot valgus deformity results in pain and debilitating disability, and causes the excessive stress on the ankle joint. Subtalar arthrodesis is often indicated in these cases to reduce the pain and to correct the talocalcaneal alignment. However, accurate correction is not easy without bone grafting, because bone defect often appears after correction. Bone grafting is necessary for accurate correction in these cases, but we have avoided it because of following reasons; donor site problem like insufficiency fractures of pelvis, supply limitation of autograft for possible multiple operations during long term disease progression of RA and the lack of bone graft substitutes, which possesses enough osteoconductivity. Now we have developed the interconnected porous calcium hydroxyapatite (IP-CHA) which possesses good osteoconductivity and achieves major incorporation with host bone much more rapid than the other porous calcium hydroxyapatite. So, we evaluated the usefulness of the packing with the newly developed IP-CHA in bone defect after correction of pes planovalgus deformity of RA patients. Methods: The best possible correction of talonavivular alignment and fixation is performed using one cubic hydroxyapatite block (1x1x1cm), staple and Kirschner wire. Then granular IP-CHA is implanted in bone defect existing mainly in talar body, gap of talonavicular joint and sinus tarsi. Six planovalgus feet were treated with subtalar arthrodesis in 4 female RA patients (3; triple arthrodesis, 3; subtalar and talonavicular arthrodesis). The average age was 56.8 years. Angle of internal arch (IA), tibiocalcaneal (TC) angle in modified Cobey’s method, talocalcaneal height (TCH) in standing position were assessed on the basis of the radiographies at just before operation and final follow-up (average 17.5 months, range 7 to 25 months). Results: Mean IA angle was 138.9 degrees pre-operatively and 132.4 at the last follow-up. Mean TC angle was 14.9 degrees pre-operatively and 7.2 at the last follow-up. No collapse or deformity of hydroxyapatite implanted in the bone defect was observed. Conclusion: Our original technique using IP-CHA was shown to prevent from initial sinking or loss of correction. This technique could make it quit easy to correct the malalignment of talocalcaneal joint with regaining of TCH in painful planovalgus deformity of RA patients

In a rabbit model we investigated the efficacy of a silk fibroin/hydroxyapatite (SF/HA) composite on the repair of a segmental bone defect. Four types of porous SF/HA composites (SF/HA-1, SF/HA-2, SF/HA-3, SF/HA-4) with different material ratios, pore sizes, porosity and additives were implanted subcutaneously into Sprague-Dawley rats to observe biodegradation. SF/HA-3, which had characteristics more suitable for a bone substitite based on strength and resorption was selected as a scaffold and co-cultured with rabbit bone-marrow stromal cells (BMSCs). A segmental bone defect was created in the rabbit radius. The animals were randomised into group 1 (SF/HA-3 combined with BMSCs implanted into the bone defect), group 2 (SF/HA implanted alone) and group 3 (nothing implanted). They were killed at four, eight and 12 weeks for visual, radiological and histological study. The bone defects had complete union for group 1 and partial union in group 2, 12 weeks after operation. There was no formation of new bone in group 3. We conclude that SF/HA-3 combined with BMSCs supports bone healing and offers potential as a bone-graft substitute

A study was undertaken to see the efficacy of backfilling the iliac crest post harvesting on postoperative pain levels and overall functional outcomes. A randomized study was undertaken in which twenty patients were divided into two groups: one received backfilling of the iliac crest with corralline hydroxyapatite and the other did not. All patients underwent posterior instrumented lumbar fusion’s with all evaluated for diagnosis, age, levels fused, and risk factors. Comparisions were made evaluating: postoperative pain, time to mobilization, rehabilitation levels, and incorporation of the corralline. Follow-up was a minimum of two years with patients still being followed. Results revealed a reduction of pain on the analog pain scale in the corralline group compared to the non-backfilled group. This was seen at three days, two weeks, one month, three months, six months, one and two years. Pain levels were reported at one at three months and zero at six months, one and two years in the corralline group compared to five at three months and four at six months and three at one and two years. Time to mobilization was one day sooner in the corralline group. Functional outcomes were seen to be better in the corralline group as well. Incorporation of the corralline hydroxyapatite was seen in all patients. Back-filling the iliac crest has shown to decrease pain, increase functional outcomes and produce a sooner time to mobilization and physical therapy than the non-filled iliac crest

Purpose of the study: The objective of this retrospective analysis was to examine the functional and radiographic results of 33 resvisions for femoral implants using a long locked stem inserted without cement and coated with hydroxyapatite. Material and methods: Mean follow-up was two years for 33 patient who underwent revison total hip arthroplasty (rTHA) with implantation of a press-fit long locked hydroxyapatite coated femoral stem (Aura or Linea) between 2000 and 2004. The explanted prosthesis was cemented in 23 cases. The reason for revision was femoral loosentng for 60%, femoral fracture for five pateints, and infection for two. According to the SOFCOT 1999 criteria, ten patients had bone defects score grade III or IV. Femorotomy was performed in 21 cases. Patients were reviewed clinically and radiologically. Function was assessed with the Postel-Merle-d’Aubligné (PMA) score and radiographic analysis determined the quality of osteointegration of the implants and the restitution of bone stock. Results: There were six early complications (one death, one disloction with sciatic paralysis), and six late complications, mainly related to defective locking. The PMA score was less than 3 for only three patients. Twenty-six patients were satisfied or very satisfied and seven patients reported thigh pain which was generally moderate. The locking was released for five prostheses because of failure or pain (relief observed in three cases). Migration was noted in three cases, illustrating their non-integration. For 15 patients, corticalisation around the lower part of the prosthesis suggested implant mobility. This image was observed in all patients who complained of thigh pain (p=0.057). There was a significant increase in the cortical index, reflecting progression of the bone stock favoring the internal cortex. Conclusion: This type of implant has provided a solution for the difficult problems of explantation and reimplantation of THA. These prostheses provide satisfactory short-term results and a significant improvement in bone stock. There remains the problem of osteointegration of certain implants. Technical factors can contribute to improved clinical results

The medium term results of the JRI Furlong Total hip replacement have been very impressive to date. We report the longest prospective series to date of a hydroxyapatite coated femoral prosthesis (Joint Replacement Instrumentation limited, London, UK) at 15–21 years follow up. We describe the long term clinical and radiological femoral stem survival of 331 consecutive JRI Furlong Hydroxyapatite coated total hip replacements in 291 patients at an average follow-up of 17.5 years (15 – 21 year). Two patients (0.6%) were lost to follow-up over the 21 years of the study period. Using revision of the femoral stem for any reason as an endpoint, we report a stem survival of 97.4 % (81.0 to 99.5). Using Aseptic loosening as an endpoint, stem survival was 100%. The average Merle, D’Aubine & Postel scores recorded for the patients was 5.63/6 for Pain, 5.42/6 for mobility and 4.50/6 for function. There were no cases of anterior thigh pain relating to the uncemented femoral stem. These results compare favourably with the best long term survival of cemented or uncemented femoral stems used in total hip replacements

The clinical use of hydroxyapatite (HA) coating is controversial especially in regard to the long-term performance of the coating and the effects of resorption. In each of 15 consenting patients we inserted two implants, coated with either HA or fluorapatite (FA) into the iliac crest. They were harvested at a mean of 13.6 ± 0.6 months after surgery. Histological examination showed that bone ongrowth on the HA-coated implants was significantly greater (29%) than that on the FA-coated implants. When bone was present on the coating surface the HA coating was significantly thicker than the FA coating. When bone marrow was present, the HA coating was significantly thinner than the FA coating. The reduction in coating thickness when covered by bone or bone marrow was 23.1 ± 9.7 μm for HA and 5.1 ± 1.7 μm for FA (p < 0.01) suggesting that FA is more stable than HA against resorption by bone marrow. The findings suggest that in man the osteoconductive properties of HA coating are superior to those of FA. Resorption rates for both coatings were approximately 20% of the coating thickness per year. Bone ongrowth appears to protect against resorption whereas bone marrow seems to accelerate resorption. No adverse reaction was seen in the surrounding bone

We carried out a histological study of a proximally hydroxyapatite (HA)-coated femoral component, retrieved after 9.5 years of good function. The HA coating had completely degraded. Bone was in direct contact with the titanium surface in all the areas which had been coated, with no interposing fibrous tissue. There were no signs of particles, third-body wear, adverse tissue reactions or osteolysis. Bone remodelling was evident by the presence of resorption lacunae; tetracycline labelling showed bone laid down six years after implantation. The loss of the HA-coating had no negative effect on the osseo-integration of the stem. We conclude that the HA coating contributes to the fixation of the implant and that its degradation does not adversely affect the long-term fixation

Introduction. We evaluated the osteogenic potential of a novel biomimetic bone paste (DBSint®), made of a combination of a human demineralized bone matrix (hDBM) and a nano-structured magnesium-enriched hydroxyapatite (Mg-HA), in a standardized clinical model of high tibial osteotomy for genu varus. Methods. A prospective, randomized, controlled study was performed and thirty patients were enrolled and assigned to three groups: DBSint® (Group I), nano-structured Mg-HA (SINTlife®) (Group II) and lyophilized-bone-chips (Group III). Six weeks after surgery, computed tomography-guided biopsies of the grafts were performed. Clinical/radiographic evaluation was performed at six weeks, twelve weeks, six months, one and 2 year after surgery, in order to verify if the graft type influenced the healing rate. Results. By histomorphometry, DBSint® was shown able to promote a quick and effective bone tissue regeneration, superior to the healing process occurred in presence of SINTlife® and lyophilized bone chips. At a mean follow up of 32,59 months, no statistical differences between the groups were found, both pre-and post-operatively, according to the Knee Society Scoring System. Mean time of ostointegration was 3,9 months in the DBSint® group, 4,2 months in the lyophilized-bone group and 4,5 in the SINTlife® group. Discussion/conclusion. Orthopedic practice may be adversely affected by an inadequate bone repair that might compromise the success of surgery. Therapy for bone regeneration with DBSint® could be particularly attractive in the treatment of patients with bone defects difficult to heal, where it could shorten the period necessary for bone regeneration, due to the higher osteogenetic potential

Diabetic foot problems are a common cause for hospitalisation in this group and up to 25% of diabetic patients will be affected. Prevalence of diabetes is rising, currently affecting 680000000 people worldwide. The enormity of this problem mandates any strategy that shortens therapeutic period and enhances success rates. Cerament G has been used in our unit as a treatment adjunct in diabetic foot treatment. Successful treatment is viewed as eradication of infection and a functional foot.

Retrospective review of 40 months practice with 115 patients. Inclusion: all diabetic feet requiring surgery Cerament G used, protocol driven Microbiology pathway. Exclusion: Primary closure not possible. Cerament G not used. Outcome assessed in three groups: Total failure (further surgery required); slow to heal (healing by secondary intention); healed without problems.

Healed 99 (eradication of infection and return to function), failure to heal 16 (success rate: 86.1%). Infection was the cause of failure in only in 2.6% (13 failures due to patient noncompliance or poor vascularity). Accepted success rate in treating osteomyelitis in diabetic feet is 68% (medical treatment only), combination of surgery and medical is 86%. Eradication of infection is the only end point return to function is not addressed. This study shows Cerament G with surgery/systemic antibiotics provides a 97.4% success rate.

Therapeutic drivers in this field have been determined traditionally by Physicians and Vascular Surgeons (resection rather than reconstructive surgery.) Our assertion is that eradicating infection in a functionally useless foot is a waste of health resources. Our strategy is always the delivery of an intact functional foot residuum. Cerament G as an adjunct allows this goal in a cost-effective manner.

Purpose. We have compared the short-term clinical results of total hip arthroplasty (THA) using PMMA bone cement and hydroxyapatite (HA) granules (interfacial bioactive bone cement method; IBBC) with the results of conventional method using PMMA bone cement. Materials and Methods. K-MAX HS-3 THA (JMM, Japan), with cemented titanium alloy stem and all polyethylene cemented socket, was used for THA implants. The third generation cement technique was used for the conventional THA (Group C) using bone cement (Endurance, DePuy). In the IBBC group (Group BC), the socket fixation was performed by the third generation cement technique with HA granules (Boneceram P; G-2, Olympus, Japan) according to the Ohnishi's method. In both groups, the stems were fixed by conventional cementing technique using cement gun. 76 hip joins (69 cases) were operated between April 2005 and August 2007, and followed. The group C (22 hips, 19 cases, average follow-up; 5.6 years, average age at operation; 64 years) and the group BC (54 hips, 50 cases, 5.4 years, 65 years) were investigated. Results. One revision was performed in BC group due to late infection. Japanese orthopaedic association (JOA) score improved from 42/48 to 85/87 in Group C/BC. Socket loosening was not observed radiographically. X-p findings of Group C/BC demonstrated radiolucent line in the outer part of Zone 1 in 18%/16% immediately after operation, 24%/23% at 2 years postoperatively. After 2 years there was no change in Group C, however, improvement of radiolucent line (gap filling) with bone remodeling was observed in two cases in Group BC at 3 years postoperatively. Conclusions. The short-term clinical results of Group BC using IBBC method and Group C using conventional method were equally satisfactory. The interesting finding in Group BC case was the improvement of radiolucent line (gap filling), suggesting osteoconductive property of hydroxyapatite granules at the interface after the operations. The promising clinical results of IBBC method in the long term were expected

We reviewed the results of 51 patients with benign bone tumours treated by curettage and implantation of calcium hydroxyapatite ceramic (CHA). The mean follow-up was 11.4 years (10 to 15.5). Post-operative fractures occurred in two patients and three had local recurrences; three had slightly limited movement of the adjacent joint and one had mild osteoarthritis. There were no allergic or neoplastic complications. In all cases, radiographs showed that the CHA was well incorporated into the host bone. Statistical analysis showed that absorption of the implanted CHA was greater in males (odds ratio, 6.2; 95% CI, 1.6 to 23.7) and younger patients (odds ratio, 0.6 for increase in age of 10 years; 95% CI, 0.91 to 0.99). However, the implanted CHA was not completely absorbed in any patient. We conclude that CHA is a useful and safe bone substitute for the treatment of benign bone tumours

We report 60 benign bone tumours treated by resection and curettage followed by the implantation of calcium hydroxyapatite ceramic (CHA). After follow-up of six to 60 months (average 36), no patient had local recurrence of the tumour or any adverse effects from the implants. In almost all cases radiography showed that the CHA was well-incorporated into the host bone, with new bone formation in and around the CHA. Corrective remodelling of deformed bone and normal fracture healing suggested that there was normal bone turnover in the presence of the CHA. Histology of biopsies from seven patients showed bone ingrowth into the pore structure of CHA in the central zone of some defects by one year after implantation. CHA appears to be a useful substitute for bone graft in the treatment of some benign tumours

Background. KAR™ prosthesis was introduced following the success of Corail® femoral stem to tackle difficult revision cases (Paprosky type1, 2a, 2b and 3a). The ARTO group reported a success rate of 94% at 17 years follow-up. Only two independent studies reported similar success rate to date. Purpose. To analyse the short-term performance of the KAR™ prosthesis used in our unit. Methods. This was a retrospective study of all KAR™ prosthesis between 2005 and 2013. Basic demographic, stem size, indications, failures and complications were recorded. X-rays were analysed for evidence of implant failure and distal cortical hypertrophy. Results. A total of 83 cases were analysed. The mean age was 68 (range 38–88 years) with an average follow-up was 3 years (range 1–8 years). The main indications for revision were aseptic loosening (83.7%), and periprosthetic fractures (7%). Kaplan-Meier Survival Rate for ‘all reasons of failure’ and ‘stem loosening’ was 93.83% and 100% respectively at 3 years follow-up. The most common reason for failure following KAR™ revision was periprosthetic fracture (3 cases). All three cases had radiographic evidence of proximal bone loss prior to index revision. Two patients developed deep infection and one patient had stem subsidence requiring revision. One patient sustained dislocation but revision surgery was not required. When comparing the effect of cortical hypertrophy, there were no significant differences in the measured distal canal/cortical diameter over the entire period of follow-up. Discussion. KAR™ prosthesis offers respectable clinical performance over a short-term period. Revision rate for this system was comparable to other ‘independent non-designer’ study. The three patients that sustained periprosthetic fracture may have been better served with a distally locked stem revision system. We believe that this HA coated implant encourages consistent osseointegration around the metaphysis region when there is evidence of a sound distal fixation. Conclusion. This study confirms that this fully coated hydroxyapatite titanium stem offers reliable clinical performance in revision arthroplasty

Background: Hydroxyapatite (HA) is the main inorganic component of bone, and HA coating is widely used on acetabular cups in hip arthroplasty. It has been suggested that this surface finish improves cup survival, but there is little evidence to support this. Patients and methods: All patients registered in the Swedish Hip Arthroplasty Register between 1992 and 2007 with an uncemented acetabular implant that was available with or without HA coating were identified. A study population of 8,043 hips with the most common cup types manufactured either with or without HA coating (Harris-Galante, Romanus and Trilogy) was investigated. Kaplan-Meier survival analysis and a Cox regression model including type of coating, age, sex, primary diagnosis, cup type, and type of stem fixation were used to calculate adjusted risk ratios (RR) of the risk for revision. Results: Kaplan-Meier analysis of all patients indicated a non-significant trend towards inferior performance of the HA-coated cups (p=0.78). When stratified for age, Kaplan-Meier analysis revealed inferior survival of HA-coated cups when compared to non-coated cups in the age group < 50 years (p=0.031). A Cox regression model showed that HA coating was a significant risk factor for cup revision due to aseptic loosening (adjusted RR 1.645; 95% CI 1.315–2.058). Age at primary arthroplasty < 50 years, a diagnosis of paediatric hip disease, a cemented stem, and the Romanus and Harris-Galante cup types were also associated with significantly increased risk for cup revision due to aseptic loosening. There was no difference in the hazard patterns when the risk for revision for any reason was chosen as the endpoint of the analysis. The risk for revision due to infection was not influenced by the type of coating. Discussion: Our results derived from register data on 8,043 hips indicate that HA coating does not enhance survival of cups when using aseptic loosening as an endpoint. On the contrary, hydroxyapatite coating is a significant risk factor for cup revision due to aseptic loosening when adjusted for other covariates such as age, sex, cup design and primary diagnosis. HA coating cannot be generally recommended as a surface treatment of acetabular cups in younger patients. This conclusion is medically and economically relevant, as many young patients today receive HA-coated cups, and because HA-coated implants are more expensive

Several bisphosphonates are now available for the treatment of osteoporosis. Porous hydroxyapatite/collagen (HA/Col) composite is an osteoconductive bone substitute which is resorbed by osteoclasts. The effects of the bisphosphonate alendronate on the formation of bone in porous HA/Col and its resorption by osteoclasts were evaluated using a rabbit model. Porous HA/Col cylinders measuring 6 mm in diameter and 8 mm in length, with a pore size of 100 μm to 500 μm and 95% porosity, were inserted into a defect produced in the lateral femoral condyles of 72 rabbits. The rabbits were divided into four groups based on the protocol of alendronate administration: the control group did not receive any alendronate, the pre group had alendronate treatment for three weeks prior to the implantation of the HA/Col, the post group had alendronate treatment following implantation until euthanasia, and the pre+post group had continuous alendronate treatment from three weeks prior to surgery until euthanasia. All rabbits were injected intravenously with either saline or alendronate (7.5 μg/kg) once a week. Each group had 18 rabbits, six in each group being killed at three, six and 12 weeks post-operatively. Alendronate administration suppressed the resorption of the implants. Additionally, the mineral densities of newly formed bone in the alendronate-treated groups were lower than those in the control group at 12 weeks post-operatively. Interestingly, the number of osteoclasts attached to the implant correlated with the extent of bone formation at three weeks. In conclusion, the systemic administration of alendronate in our rabbit model at a dose-for-weight equivalent to the clinical dose used in the treatment of osteoporosis in Japan affected the mineral density and remodelling of bone tissue in implanted porous HA/Col composites

We investigated the effects of hydroxyapatite (HA) coating on the purchase of pedicle screws. A total of 23 consecutive patients undergoing lumbar fusion was randomly assigned to one of three treatment groups. The first received uncoated stainless-steel screws, the second screws which were partly coated with HA, and the third screws which were fully coated. The insertion torque was recorded. After 11 to 16 months, 21 screws had been extracted. The extraction torque was recorded. Radiographs were taken to assess fusion and to detect loosening of the screws. At removal, the extraction torques exceeded the upper limit of the torque wrench (600 Ncm) for many HA-coated screws. The calculated mean extraction torque was 29 ± 36 Ncm for the uncoated group, 447 ± 114 Ncm for the partly-coated group and 574 ± 52 Ncm for the fully-coated group. There were significant differences between all three groups (p < 0.001). There were more radiolucent zones surrounding the uncoated screws than the HA-coated screws (p < 0.001). HA coating of pedicle screws resulted in improved fixation with reduced risk of loosening of the screws